<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:23:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10358993" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10358993</identifier>
        <datestamp>2023-07-21</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10358993</article-id>
              <article-id pub-id-type="pmcid">PMC10358993</article-id>
              <article-id pub-id-type="pmc-uid">10358993</article-id>
              <article-id pub-id-type="pmid">37471317</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0288544</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-23-05677</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Addiction</subject>
                      <subj-group>
                        <subject>Nicotine Addiction</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Addiction</subject>
                      <subj-group>
                        <subject>Nicotine Addiction</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Substance-Related Disorders</subject>
                      <subj-group>
                        <subject>Nicotine Addiction</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Public and Occupational Health</subject>
                    <subj-group>
                      <subject>Substance-Related Disorders</subject>
                      <subj-group>
                        <subject>Nicotine Addiction</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Behavior</subject>
                      <subj-group>
                        <subject>Habits</subject>
                        <subj-group>
                          <subject>Smoking Habits</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Behavior</subject>
                      <subj-group>
                        <subject>Habits</subject>
                        <subj-group>
                          <subject>Smoking Habits</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Emotions</subject>
                      <subj-group>
                        <subject>Anxiety</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Emotions</subject>
                      <subj-group>
                        <subject>Anxiety</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Chemistry</subject>
                    <subj-group>
                      <subject>Chemical Compounds</subject>
                      <subj-group>
                        <subject>Alkaloids</subject>
                        <subj-group>
                          <subject>Nicotine</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Neuroscience</subject>
                    <subj-group>
                      <subject>Brain Mapping</subject>
                      <subj-group>
                        <subject>Functional Magnetic Resonance Imaging</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Diagnostic Radiology</subject>
                      <subj-group>
                        <subject>Magnetic Resonance Imaging</subject>
                        <subj-group>
                          <subject>Functional Magnetic Resonance Imaging</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Imaging Techniques</subject>
                    <subj-group>
                      <subject>Diagnostic Radiology</subject>
                      <subj-group>
                        <subject>Magnetic Resonance Imaging</subject>
                        <subj-group>
                          <subject>Functional Magnetic Resonance Imaging</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Radiology and Imaging</subject>
                    <subj-group>
                      <subject>Diagnostic Radiology</subject>
                      <subj-group>
                        <subject>Magnetic Resonance Imaging</subject>
                        <subj-group>
                          <subject>Functional Magnetic Resonance Imaging</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Imaging Techniques</subject>
                    <subj-group>
                      <subject>Neuroimaging</subject>
                      <subj-group>
                        <subject>Functional Magnetic Resonance Imaging</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Neuroscience</subject>
                    <subj-group>
                      <subject>Neuroimaging</subject>
                      <subj-group>
                        <subject>Functional Magnetic Resonance Imaging</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Brain</subject>
                      <subj-group>
                        <subject>Amygdala</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Brain</subject>
                      <subj-group>
                        <subject>Amygdala</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Imaging Techniques</subject>
                    <subj-group>
                      <subject>Neuroimaging</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Neuroscience</subject>
                    <subj-group>
                      <subject>Neuroimaging</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Acute nicotine abstinence amplifies subjective withdrawal symptoms and threat-evoked fear and anxiety, but not extended amygdala reactivity</article-title>
                <alt-title alt-title-type="running-head">Nicotine abstinence amplifies withdrawal and distress, not extended amygdala function</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1804-1244</contrib-id>
                  <name>
                    <surname>Kim</surname>
                    <given-names>Hyung Cho</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2753-8225</contrib-id>
                  <name>
                    <surname>Kaplan</surname>
                    <given-names>Claire M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3238-7740</contrib-id>
                  <name>
                    <surname>Islam</surname>
                    <given-names>Samiha</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Anderson</surname>
                    <given-names>Allegra S.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Piper</surname>
                    <given-names>Megan E.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bradford</surname>
                    <given-names>Daniel E.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Curtin</surname>
                    <given-names>John J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>DeYoung</surname>
                    <given-names>Kathryn A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Smith</surname>
                    <given-names>Jason F.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0695-3323</contrib-id>
                  <name>
                    <surname>Fox</surname>
                    <given-names>Andrew S.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Shackman</surname>
                    <given-names>Alexander J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="aff011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Psychology, University of Maryland, College Park, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Neuroscience and Cognitive Science Program, University of Maryland, College Park, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Psychology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Department of Psychological Sciences, Vanderbilt University, Nashville, Tennessee, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Center for Tobacco Research and Intervention and Department of Medicine, School of Medicine and Public Health, University of Wisconsin—Madison, Madison, Wisconsin, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>School of Psychological Sciences, Oregon State University, Corvallis, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Department of Psychology, University of Wisconsin—Madison, Madison, Wisconsin, United States of America</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Department of Psychology, University of California, Davis, California, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>California National Primate Research Center, University of California, Davis, California, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Maryland Neuroimaging Center, University of Maryland, College Park, Maryland, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Oathes</surname>
                    <given-names>Desmond J.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of Pennsylvania Perelman School of Medicine, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>hkim1230@umd.edu</email> (HCK); <email>shackman@umd.edu</email> (AJS)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>7</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>7</issue>
              <elocation-id>e0288544</elocation-id>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>6</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Kim et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Kim et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0288544.pdf"/>
              <abstract>
                <p>Tobacco smoking imposes a staggering burden on public health, underscoring the urgency of developing a deeper understanding of the processes that maintain addiction. Clinical and experience-sampling data highlight the importance of anxious withdrawal symptoms, but the underlying neurobiology has remained elusive. Mechanistic work in animals implicates the central extended amygdala (EAc)—including the central nucleus of the amygdala and the neighboring bed nucleus of the stria terminalis—but the translational relevance of these discoveries remains unexplored. Here we leveraged a randomized trial design, well-established threat-anticipation paradigm, and multidimensional battery of assessments to understand the consequences of 24-hour nicotine abstinence. The threat-anticipation paradigm had the expected consequences, amplifying subjective distress and arousal, and recruiting the canonical threat-anticipation network. Abstinence increased smoking urges and withdrawal symptoms, and potentiated threat-evoked distress, but had negligible consequences for EAc threat reactivity, raising questions about the translational relevance of prominent animal and human models of addiction. These observations provide a framework for conceptualizing nicotine abstinence and withdrawal, with implications for basic, translational, and clinical science.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>AA031261, DA040717, MH107444, MH121409, MH121735, MH131264, MH129851, MH018921, OD011107,</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Shackman</surname>
                      <given-names>Alexander J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000001</institution-id>
                      <institution>National Science Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>DGE-1632976</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1804-1244</contrib-id>
                    <name>
                      <surname>Kim</surname>
                      <given-names>Hyung Cho</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008510</institution-id>
                      <institution>University of Maryland</institution>
                    </institution-wrap>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Shackman</surname>
                      <given-names>Alexander J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This work was supported by the California National Primate Center, National Institutes of Health (AA031261, DA040717, MH107444, MH121409, MH121735, MH131264, MH129851, MH018921, OD011107, Awarded: Dr. Alexander Shackman), National Science Foundation (DGE-1632976, Awarded: Hyung Cho Kim), and University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="1"/>
                <page-count count="31"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Statistical code and processed data are available via OSF (<ext-link xlink:href="https://osf.io/zmk4v" ext-link-type="uri">https://osf.io/zmk4v</ext-link>). Key neuroimaging maps are publicly available via NeuroVault (<ext-link xlink:href="https://neurovault.org/images/786541" ext-link-type="uri">https://neurovault.org/images/786541</ext-link>).</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Statistical code and processed data are available via OSF (<ext-link xlink:href="https://osf.io/zmk4v" ext-link-type="uri">https://osf.io/zmk4v</ext-link>). Key neuroimaging maps are publicly available via NeuroVault (<ext-link xlink:href="https://neurovault.org/images/786541" ext-link-type="uri">https://neurovault.org/images/786541</ext-link>).</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Tobacco smoking is a leading preventable cause of disease, disability, and premature death in the U.S. and abroad [<xref rid="pone.0288544.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>]. More than 1 in 7 U.S. adults (15.2%) regularly smoke tobacco [<xref rid="pone.0288544.ref003" ref-type="bibr">3</xref>]. The annual economic burden of tobacco smoking has been estimated at more than $600 billion in the U.S. alone [<xref rid="pone.0288544.ref004" ref-type="bibr">4</xref>]. Although the dangers of smoking are clear and most smokers (~68%) want to quit, relapse is common and existing cessation aids are far from curative, underscoring the importance of developing a deeper understanding of the mechanisms that maintain nicotine use in humans [<xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0288544.ref006" ref-type="bibr">6</xref>].</p>
              <p>The transition from tobacco use to nicotine dependence is undoubtedly complex and dynamic, encompassing alterations in multiple motivational and self-regulatory mechanisms [<xref rid="pone.0288544.ref007" ref-type="bibr">7</xref>–<xref rid="pone.0288544.ref011" ref-type="bibr">11</xref>]. Among them, there is abundant clinical, experience-sampling, and experimental work demonstrating that anxiety and negative reinforcement mechanisms—smoking to alleviate ‘tension’ and emotional distress—play a central role in nicotine dependence and relapse [<xref rid="pone.0288544.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0288544.ref017" ref-type="bibr">17</xref>]. Acute nicotine abstinence is associated with heightened negative emotions—with the strongest meta-analytic effects evident for anxiety (<italic toggle="yes">d</italic> = .63)—and anxiety serves as a diagnostic criterion for nicotine withdrawal in DSM-5 [<xref rid="pone.0288544.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0288544.ref020" ref-type="bibr">20</xref>]. Daily diary and ecological momentary assessment (EMA) studies paint a similar picture, showing that nicotine abstinence leads to pervasive increases in tonic anxiety and amplified reactivity to social conflict and other daily stressors [<xref rid="pone.0288544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0288544.ref022" ref-type="bibr">22</xref>]. The accompanying phasic surges in anxiety and other negative emotions (e.g., anger) are, in turn, associated with heightened risk of relapse during cessation attempts [<xref rid="pone.0288544.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0288544.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0288544.ref027" ref-type="bibr">27</xref>]. Parallel results have been found in laboratory settings, where experimental stressors trigger nicotine craving and promote consumption [<xref rid="pone.0288544.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0288544.ref030" ref-type="bibr">30</xref>]. In sum, acute nicotine abstinence potently increases both tonic (stressor-independent) and reactive (stressor-dependent) anxiety in ways that promote continued nicotine use, with some experimental research suggesting that hyper-reactivity may be particularly evident for temporally uncertain stressors [<xref rid="pone.0288544.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>, but see <xref rid="pone.0288544.ref032" ref-type="bibr">32</xref>]. Despite this progress, the neural circuitry underlying withdrawal-related anxiety has remained unclear, impeding the development of more effective or tolerable biological treatments.</p>
              <p>Mechanistic studies in rats and mice motivate the popular hypothesis that withdrawal-related anxiety and stress-induced reinstatement of nicotine use reflect functional alterations in the central extended amygdala (EAc) [<xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0288544.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0288544.ref010" ref-type="bibr">10</xref>], including the central nucleus of the amygdala (Ce) and neighboring bed nucleus of the stria terminalis (BST) [<xref rid="pone.0288544.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0288544.ref034" ref-type="bibr">34</xref>]. Among nicotine-dependent rodents, acute deprivation is associated with heightened signs of anxiety across a range of threat assays and defensive behaviors (e.g., shock-probe burying) [<xref rid="pone.0288544.ref035" ref-type="bibr">35</xref>]. Focal perturbation studies show that nicotine deprivation-induced increases in anxiety-related behaviors and stress-induced reinstatement of nicotine use critically depend on specific molecular (e.g., corticotrophin-releasing hormone, CRH; norepinephrine) signaling mechanisms in the EAc (Ce/BST), with overlapping effects evident for other addictive substances [<xref rid="pone.0288544.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0288544.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0288544.ref038" ref-type="bibr">38</xref>]. Yet the relevance of these tantalizing neurobiological discoveries to the complexities of the human brain and human withdrawal remains unclear. Humans and rodents diverged ~80 million years ago, leading to marked behavioral, genetic, and neurobiological differences between the two species [<xref rid="pone.0288544.ref039" ref-type="bibr">39</xref>–<xref rid="pone.0288544.ref041" ref-type="bibr">41</xref>]. Whether the EAc (Ce/BST) circuitry implicated in rodent models of anxious withdrawal is evolutionarily conserved in human tobacco smokers experiencing acute nicotine abstinence remains unexplored and unknown.</p>
              <p>Here we used a novel combination of assessments—including questionnaire measures of smoking urges and withdrawal, a well-established certain/uncertain threat-anticipation (‘threat-of-shock’) paradigm, ratings of threat-evoked fear and anxiety, a psychophysiological (skin conductance) measure of threat-evoked arousal, and functional MRI (fMRI)—and a between-subjects randomized trial design to understand the subjective and biological consequences of 24-hour nicotine abstinence in a racially diverse sample of 75 daily tobacco smokers (<bold><xref rid="pone.0288544.g001" ref-type="fig">Fig 1</xref></bold>). Prior work demonstrates that the threat-anticipation paradigm elicits robust distress and arousal [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>]. This stands in stark contrast to popular ‘threat-related’ emotional face fMRI paradigms [<xref rid="pone.0288544.ref044" ref-type="bibr">44</xref>–<xref rid="pone.0288544.ref046" ref-type="bibr">46</xref>], which do not elicit distress in typical adults and are better conceptualized as probes of emotion perception [<xref rid="pone.0288544.ref047" ref-type="bibr">47</xref>]. A best-practices fMRI pipeline enhanced our ability to resolve the Ce and BST, the two major subdivisions of the EAc. Anatomically defined regions-of-interest (ROIs) made it possible to test the central hypothesis that EAc (Ce/BST) threat reactivity would be potentiated in the 24-Hour Abstinence group (vs. Smoke-as-Usual), and to explore the possibility that this anticipated hyper-reactivity would be more evident during the anticipation of temporally Uncertain Threat [<xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>, but see <xref rid="pone.0288544.ref032" ref-type="bibr">32</xref>]. In contrast to whole-brain voxelwise analyses—which screen thousands of voxels for evidence of statistical significance and yield optimistic effect size estimates in suprathreshold regions—anatomically defined ROIs ‘fix’ the outcomes of interest <italic toggle="yes">a priori</italic>, providing statistically unbiased estimates of brain-phenotype associations [i.e., effect sizes; <xref rid="pone.0288544.ref048" ref-type="bibr">48</xref>].</p>
              <fig position="float" id="pone.0288544.g001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0288544.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>Study overview.</title>
                  <p><bold><italic toggle="yes">Top three panels</italic>. (1)</bold> A racially diverse group of 75 daily tobacco smokers was recruited from the community. A multi-stage screening process—including a baseline assessment of breath carbon monoxide (CO) levels—was used to assess eligibility. At the baseline laboratory session, participants completed questionnaire measures of tobacco use and dependence. <bold>(2)</bold> Participants were randomized to either the Smoke-as-Usual or 24-Hour Abstinence groups, stratified by age and sex. <bold>(3)</bold> At the neuroimaging session, protocol compliance was confirmed by breath CO. Prior to scanning, smoking urges and withdrawal symptoms were assessed. During scanning, participants completed a well-established threat-anticipation paradigm that encompassed measures of threat-evoked distress, physiological arousal, and brain function. <bold><italic toggle="yes">Bottom two panels</italic>. Threat-Anticipation Paradigm</bold>. As shown schematically in the bottom-left panel, the threat-anticipation paradigm took the form of a 2 (<italic toggle="yes">Valence</italic>: Threat/Safety) × 2 (<italic toggle="yes">Temporal Certainty</italic>: Certain/Uncertain) repeated-measures, randomized event-related design. Subjects were completely informed about the task design and contingencies prior to scanning. On Certain Threat trials, subjects saw a descending stream of integers (‘count-down’) for 18.75 s. To ensure robust distress, the anticipation epoch culminated in the delivery of a noxious electric shock, unpleasant photographic image, and thematically related audio clip (e.g., scream). Uncertain Threat trials were similar, but the integer stream was randomized and presented for an uncertain and variable duration (8.75–30.00 s). Participants knew that something aversive was going to occur, but they had no way of knowing precisely <italic toggle="yes">when</italic>. Safety trials were similar, but terminated with the delivery of benign reinforcers (e.g., just-perceptible electrical stimulation). Mean duration of the anticipation epochs was identical across conditions. Subjects were periodically prompted to rate the intensity of fear/anxiety experienced during the anticipation period of the prior trial. Skin conductance was continuously acquired throughout. <bold>Neuroimaging Analyses.</bold> As shown schematically in the bottom-right panel, two approaches were used to test the impact of acute hour nicotine abstinence on neural reactivity to threat. Guided by mechanistic work in animal models, hypothesis testing focused on two well-established, anatomically defined EAc regions-of-interest (ROIs): the Ce (<italic toggle="yes">left</italic>) and BST (<italic toggle="yes">right</italic>). Because the ROIs (i.e., voxel-level measurements) were chosen <italic toggle="yes">a priori</italic>—on the basis of anatomy, rather than suprathreshold threat reactivity—this approach provides unbiased effect size estimates [<xref rid="pone.0288544.ref048" ref-type="bibr">48</xref>]. Standardized regression coefficients were extracted and averaged across voxels for each combination of ROI, threat type (Uncertain/Certain), and participant. Hypothesis testing used a standard mixed-effects general linear model (GLM). For illustrative purposes, 1-mm ROIs are shown. Analyses employed ROIs decimated to the 2-mm resolution of the fMRI data. As shown schematically in the bottom-right panel, exploratory whole-brain voxelwise analyses were also performed. Abbreviations—BST, bed nucleus of the stria terminalis; Ce, central nucleus of the amygdala; fMRI, functional magnetic resonance imaging; hrs., hours; <italic toggle="yes">M</italic>, mean; s, seconds.</p>
                </caption>
                <graphic xlink:href="pone.0288544.g001" position="float"/>
              </fig>
              <p>Understanding the impact of nicotine abstinence on human EAc reactivity is conceptually and practically important. It affords an opportunity to assess the translational relevance of influential neurobiological models of addiction derived almost exclusively from work in rodents [<xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>]. Successful translation across species would prioritize EAc targets for nicotine-related treatment development and testing [<xref rid="pone.0288544.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0288544.ref050" ref-type="bibr">50</xref>]. Discrepancies across species would point to the need to refine animal models, human paradigms, or both. Both outcomes would inform the development of bidirectional translational models of nicotine dependence, withdrawal, and relapse. While not a central goal, the present project also promises to shed new light on the neural systems recruited by certain and uncertain threat anticipation, a key question for many fear and anxiety researchers [<xref rid="pone.0288544.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0288544.ref051" ref-type="bibr">51</xref>–<xref rid="pone.0288544.ref057" ref-type="bibr">57</xref>].</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Method</title>
              <p>In this section, we report how we determined our sample size, all data exclusions, all manipulations, and all measures in the study.</p>
              <sec id="sec003">
                <title>Participants and enrollment criteria</title>
                <p>Seventy-eight daily tobacco smokers were enrolled and scanned. Eligibility was determined using a multi-stage procedure that included on-line, telephone, and face-to-face assessments. Eligibility criteria included: 18–40 years old; smoke at least 10 cigarettes/day for at least 6 months; baseline breath carbon monoxide (CO) level of ≥8 parts per million (ppm) at baseline; normal or corrected-to-normal color vision; English proficiency; and self-reported absence of a non-nicotine substance use disorder, lifetime psychotic or bipolar disorder, lifetime neurological or pervasive developmental disorder, very premature birth, current psychiatric treatment, MRI contraindications, or prior experience with aversive electrical stimulation. Similar tobacco-use and carbon-monoxide criteria have been used in prior laboratory studies and clinical trials [e.g. <xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0288544.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0288544.ref058" ref-type="bibr">58</xref>, <xref rid="pone.0288544.ref059" ref-type="bibr">59</xref>]. Ten or more cigarettes per day is considered a ‘moderate’ level of tobacco use [<xref rid="pone.0288544.ref060" ref-type="bibr">60</xref>]. All participants provided informed written consent. Procedures were approved by the University of Maryland, College Park Institutional Review Board (protocol #824438). Data from this project have not been featured in any prior publications.</p>
                <p>Three individuals were excluded from all analyses due to study withdrawal (<italic toggle="yes">n</italic> = 1) or inadequate task compliance (<italic toggle="yes">n</italic> = 2; see below). The final sample of 75 participants was racially diverse (<italic toggle="yes">M</italic> = 30.05 years, <italic toggle="yes">SD</italic> = 5.64; 33.3% female; 49.3% African American, 25.3% White Non-Hispanic, 12.0% Asian, 9.4% Multiracial/Other, 4.0% Hispanic or Latino/a), enhancing equity and generalizability [<xref rid="pone.0288544.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0288544.ref062" ref-type="bibr">62</xref>]. Educational attainment and income data are provided in <bold><xref rid="pone.0288544.s002" ref-type="supplementary-material">S1</xref> and <xref rid="pone.0288544.s003" ref-type="supplementary-material">S2</xref> Tables</bold>. As detailed in <bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>, the Smoke-as-Usual and 24-Hour Abstinence groups were well matched. The two groups also did not differ in their general engagement with the MTC paradigm, as indexed by the proportion of ratings completed (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>). Sensitivity analyses performed using Welch’s <italic toggle="yes">t</italic>-test yielded identical conclusions (not reported). All participants showed acceptable levels of head-motion artifact, as detailed below.</p>
                <table-wrap position="float" id="pone.0288544.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0288544.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Descriptive statistics for the complete sample, Smoke-as-Usual group, and 24-Hour Abstinence group.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0288544.t001" id="pone.0288544.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">Complete Sample</th>
                          <th align="left" rowspan="1" colspan="1">Smoke-as-Usual</th>
                          <th align="left" rowspan="1" colspan="1">24-hour Abstinence</th>
                          <th align="left" rowspan="1" colspan="1">Group Differences</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline demographic variables</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>
                              <italic toggle="yes">Total N</italic>
                            </bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">75</td>
                          <td align="left" rowspan="1" colspan="1">37</td>
                          <td align="left" rowspan="1" colspan="1">38</td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>
                              <italic toggle="yes">Female N</italic>
                            </bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">25</td>
                          <td align="left" rowspan="1" colspan="1">15</td>
                          <td align="left" rowspan="1" colspan="1">10</td>
                          <td align="left" rowspan="1" colspan="1">χ2 = 1.12, <italic toggle="yes">p</italic> = 0.28</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>
                              <italic toggle="yes">Age (years)</italic>
                            </bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">30.05 (5.64)</td>
                          <td align="left" rowspan="1" colspan="1">30.11 (5.53)</td>
                          <td align="left" rowspan="1" colspan="1">30 (5.81)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -0.08, <italic toggle="yes">p</italic> = 0.93</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Years smoked</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">11.89 (6.49)</td>
                          <td align="left" rowspan="1" colspan="1">12.03 (6.86)</td>
                          <td align="left" rowspan="1" colspan="1">11.76 (6.19)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -0.17, <italic toggle="yes">p</italic> = 0.86</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Cigarettes/day</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">13.47 (4.46)</td>
                          <td align="left" rowspan="1" colspan="1">13.05 (4.58)</td>
                          <td align="left" rowspan="1" colspan="1">13.87 (4.36)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 0.78, <italic toggle="yes">p</italic> = 0.43</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">FTCD score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">5.71 (1.38)</td>
                          <td align="left" rowspan="1" colspan="1">5.65 (1.44)</td>
                          <td align="left" rowspan="1" colspan="1">5.78 (1.33)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 0.39, <italic toggle="yes">p</italic> = 0.69</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">WISDM total score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">52.42 (14.56)</td>
                          <td align="left" rowspan="1" colspan="1">50.33 (12.18)</td>
                          <td align="left" rowspan="1" colspan="1">54.46 (16.46)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 1.23, <italic toggle="yes">p</italic> = 0.22</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">WISDM negative reinforcement subscale score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">4.72 (1.49)</td>
                          <td align="left" rowspan="1" colspan="1">4.67 (1.34)</td>
                          <td align="left" rowspan="1" colspan="1">4.78 (1.64)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 0.33, <italic toggle="yes">p</italic> = 0.73</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Baseline CO level (ppm)</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">26.4 (14.75)</td>
                          <td align="left" rowspan="1" colspan="1">28.95 (17.63)</td>
                          <td align="left" rowspan="1" colspan="1">23.92 (10.94)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -1.48, <italic toggle="yes">p</italic> = 0.14</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Neuroimaging session variables</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">WSWS total score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                          <td align="left" rowspan="1" colspan="1">36.68 (12.03)</td>
                          <td align="left" rowspan="1" colspan="1">61.97 (18.50)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 7.00, <italic toggle="yes">p</italic>&lt;0.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">WSWS anxiety subscale score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                          <td align="left" rowspan="1" colspan="1">5.08 (3.29)</td>
                          <td align="left" rowspan="1" colspan="1">9.29 (3.66)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 5.23, <italic toggle="yes">p</italic>&lt;0.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">BQSU score</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                          <td align="left" rowspan="1" colspan="1">26.38 (13.03)</td>
                          <td align="left" rowspan="1" colspan="1">54.29 (10.83)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = 10.09, <italic toggle="yes">p</italic>&lt;0.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Experimental CO level (ppm)</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                            <xref rid="t001fn001" ref-type="table-fn">
                              <sup>
                                <bold>
                                  <italic toggle="yes">a</italic>
                                </bold>
                              </sup>
                            </xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                          <td align="left" rowspan="1" colspan="1">35.75 (41.36)</td>
                          <td align="left" rowspan="1" colspan="1">3.35 (5.84)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -4.78, <italic toggle="yes">p</italic>&lt;0.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Aversive electrical stimulation level (V)</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">121.33 (45.14)</td>
                          <td align="left" rowspan="1" colspan="1">121.73 (45.35)</td>
                          <td align="left" rowspan="1" colspan="1">120.95 (45.53)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -0.07, <italic toggle="yes">p</italic> = 0.94</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Benign electrical stimulation level (V)</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">24.43 (5.48)</td>
                          <td align="left" rowspan="1" colspan="1">24.70 (5.42)</td>
                          <td align="left" rowspan="1" colspan="1">24.16 (5.59)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -0.42, <italic toggle="yes">p</italic> = 0.66</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold><italic toggle="yes">Ratings Completed (%)</italic>, <italic toggle="yes">mean (SD)</italic></bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">94.95 (9.88)</td>
                          <td align="left" rowspan="1" colspan="1">96.33 (8.52)</td>
                          <td align="left" rowspan="1" colspan="1">93.61 (10.99)</td>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">t</italic>(73) = -1.19, <italic toggle="yes">p</italic> = 0.23</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p><sup>a</sup> CO levels at the neuroimaging session were also significantly reduced in the 24-Hour Abstinence group relative to their own baseline levels. <italic toggle="yes">t</italic>(37) = 11.27, <italic toggle="yes">p</italic> &lt; .001. Abbreviations—BQSU, Brief Questionnaire of Smoking Urges; CO, carbon monoxide; FTND, Fagerstrom Test for Cigarette Dependence; ppm, parts per million; <italic toggle="yes">SD</italic>, standard deviation; V, volts; WISDM, Wisconsin Inventory of Smoking Dependence Motives; WSWS: Wisconsin Smoking Withdrawal Scale.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec004">
                <title>Power analysis</title>
                <p>Sample size was determined <italic toggle="yes">a priori</italic> as part of the application for the grant that supported data collection (R21-DA040717). The target sample size (<italic toggle="yes">n</italic>≈72) was chosen to afford acceptable power and precision given available resources. At the time of study design, Gpower (version 3.1.9.2) indicated 88.3% power to detect a benchmark “large” group mean difference (<italic toggle="yes">d</italic> = .80) with 10% planned attrition (<italic toggle="yes">n</italic> = 32/group; <italic toggle="yes">df</italic> = 63) using α<sub><italic toggle="yes">two-tailed</italic></sub> = .05 [<xref rid="pone.0288544.ref063" ref-type="bibr">63</xref>]. In practice, funds were available to support the enrollment of 78 participants. With the exception of quality assurance checks performed using data from the first few participants, all analyses were performed following the acquisition of the entire dataset. The final sample (n = 75; <bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>) was comparable to or larger than many prior studies focused on threat reactivity in acutely abstinent tobacco smokers [<xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0288544.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0288544.ref064" ref-type="bibr">64</xref>]. A post hoc power analysis indicated that the final sample was powered to detect medium-to-large effects (power &gt;80% for <italic toggle="yes">d</italic>&gt;.66).</p>
              </sec>
              <sec id="sec005">
                <title>General procedures</title>
                <sec id="sec006">
                  <title>Recruitment</title>
                  <p>Daily tobacco smokers from the DC-Baltimore metropolitan region were recruited using a combination of on-line (e.g., posts to social media platforms and groups) and off-line advertisements (e.g., fliers and business cards distributed at high-traffic local restaurants, coffee shops, and libraries). Preliminary eligibility was determined using a multi-stage screening process that included on-line surveys and a telephone screening.</p>
                </sec>
                <sec id="sec007">
                  <title>Baseline laboratory session</title>
                  <p>Potentially eligible individuals were invited to a baseline laboratory session. Smoking status was biochemically verified using a Micro+ Smokerlyzer (coVita, Santa Barbara, CA). All participants demonstrated an exhaled CO level of at least 8 ppm, averaged across three serial tests (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>). Participants also completed a battery of standardized measures of tobacco use and dependence. Participants were then randomly assigned to either the Smoke-as-Usual (SAU) or 24-Hour Abstinence group, stratified by age and sex. The Smoke-as-Usual group was instructed to continue their normal smoking habits prior to their neuroimaging session, whereas the 24-Hour Abstinence group was instructed to refrain from smoking or using any other nicotine products for 24 hours prior to the scheduled neuroimaging session. To encourage protocol compliance, a series of email and text message reminders was sent prior to and during the final 24 hours.</p>
                </sec>
                <sec id="sec008">
                  <title>Neuroimaging session</title>
                  <p>Upon arrival at the neuroimaging session, protocol compliance was assessed. For the 24-Hour Abstinence group, participants were allowed to proceed with scanning upon self-reporting nicotine abstinence and receiving a CO reading of &lt;50% of their baseline level. Participants in the Smoke-as-Usual group demonstrated CO levels of at least 8 ppm. By design, measured CO levels were significantly reduced in the 24-Hour Abstinence group (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>). Prior to scanning, participants were offered a brief break, and those in the Smoke-as-Usual group were encouraged to smoke <italic toggle="yes">ad libitum</italic>. Prior to scanning, participants completed a battery of standardized questionnaires assessing smoking urges and withdrawal symptoms (see below). During scanning, foam inserts were used to immobilize the participant’s head within the head-coil and mitigate potential motion artifact. Participants were continuously monitored using an MRI-compatible eye-tracker (Eyelink 1000; SR Research, Ottawa, Ontario, Canada) and the AFNI real-time motion plugin [<xref rid="pone.0288544.ref065" ref-type="bibr">65</xref>]. Measures of respiration and breathing were continuously acquired during scanning using a respiration belt and photo-plethysmograph affixed to the first digit of the non-dominant hand. Following the last scan, participants were removed from the scanner, debriefed, compensated, and discharged.</p>
                </sec>
              </sec>
              <sec id="sec009">
                <title>Measures of nicotine use and dependence</title>
                <sec id="sec010">
                  <title>Fagerstrom Test for Cigarette Dependence (FTCD)</title>
                  <p>To assess potential group differences in nicotine dependence, participants completed the FTCD (6-items) at the baseline laboratory session [<xref rid="pone.0288544.ref066" ref-type="bibr">66</xref>–<xref rid="pone.0288544.ref068" ref-type="bibr">68</xref>]. Yes-or-no items are rated as 1-or-0. Multiple-choice items are rated from 0 to 3. Higher total (sum) scores indicate greater nicotine dependence.</p>
                </sec>
                <sec id="sec011">
                  <title>Wisconsin Inventory of Smoking Dependence Motives (WISDM)</title>
                  <p>To assess potential group differences in general and negative reinforcement-specific tobacco smoking motivation, participants completed the WISDM (68 items) at the baseline laboratory session [<xref rid="pone.0288544.ref069" ref-type="bibr">69</xref>]. Items are rated on a 7-point scale, with 1 indicating ‘not true of me at all’ and 7 indicating ‘extremely true of me’. The total score is the sum of the means across subscales. The total scale (68 items, α = .97) and negative-reinforcement facet scale (6 items, α = .88) were calculated for each participant. Higher scores indicate greater nicotine dependence.</p>
                </sec>
                <sec id="sec012">
                  <title>Wisconsin Smoking Withdrawal Scale (WSWS)</title>
                  <p>To assess general and anxiety-specific symptoms of nicotine withdrawal syndrome and to verify protocol compliance, participants completed the WSWS (28 items) at the neuroimaging session [<xref rid="pone.0288544.ref070" ref-type="bibr">70</xref>]. Items are rated on a 5-point scale, with 0 indicating ‘strongly disagree’ and 4 indicating ‘strongly agree’. Items are summed to generate a score for each subscale and a total score. The total scale (28 items, α = .94) and anxiety subscale score (4 items, α = .83) were calculated for each participant. Higher scores indicate greater nicotine withdrawal symptoms.</p>
                </sec>
                <sec id="sec013">
                  <title>Brief Questionnaire of Smoking Urges (BQSU)</title>
                  <p>To assess tobacco smoking craving and to verify protocol compliance, participants completed the BQSU (10 items) at the neuroimaging session (West &amp; Ussher, 2009). Items are rated on a 7-point scale, with 1 indicating ‘strongly disagree’ and 7 indicating ‘strongly agree’. Items are summed to generate a score for each subscale and a total score. The total score (10 items, α = .96) was calculated for each participant. Higher scores indicate greater smoking urges/craving.</p>
                </sec>
              </sec>
              <sec id="sec014">
                <title>Threat-anticipation paradigm</title>
                <sec id="sec015">
                  <title>Paradigm structure and design considerations</title>
                  <p>The Maryland Threat Countdown (MTC) is a well-established, fMRI-optimized version of temporally uncertain-threat assays previously validated using fear-potentiated startle and acute anxiolytic administration (e.g., benzodiazepine) in mice [<xref rid="pone.0288544.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0288544.ref072" ref-type="bibr">72</xref>], rats [<xref rid="pone.0288544.ref073" ref-type="bibr">73</xref>], and humans [<xref rid="pone.0288544.ref074" ref-type="bibr">74</xref>]. The MTC has been successfully used in a number of human fMRI studies [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>].</p>
                  <p>The MTC paradigm (<bold><xref rid="pone.0288544.g001" ref-type="fig">Fig 1</xref></bold>) takes the form of a 2 (<italic toggle="yes">Valence</italic>: Threat/Safety) × 2 (<italic toggle="yes">Temporal Certainty</italic>: Uncertain/Certain) randomized, event-related, repeated-measures design (3 scans; 6 trials/condition/scan). Subjects were completely informed about the task design and contingencies prior to scanning. Simulations were used to optimize the detection and deconvolution of task-related hemodynamic signals (variance inflation factors &lt;1.54). Stimulus presentation and ratings acquisition were controlled using Presentation software (version 19.0, Neurobehavioral Systems, Berkeley, CA).</p>
                  <p>Valence was continuously signaled during the anticipation epoch by the background color of the display. Trial certainty was signaled by the nature of the integer stream. On Certain Threat trials, subjects saw a descending stream of integers (‘count-down;’ 30, 29, 28. . .3, 2, 1) for 18.75 s (0.625 s/integer). To ensure robust distress, this anticipation epoch always culminated with the delivery of a noxious electric shock, unpleasant photographic image (e.g., mutilated body), and thematically related audio clip (e.g., scream, gunshot). Uncertain Threat trials were similar, but the integer stream was randomized and presented for an uncertain and variable duration (8.75–30.00 s). Here, participants knew that something aversive was going to occur, but they had no way of knowing precisely <italic toggle="yes">when</italic>. Safety trials were similar, but terminated with the delivery of benign reinforcers (i.e., just-perceptible electrical stimulation and neutral audiovisual stimuli). Mean duration of the anticipation epochs was identical across trial types, ensuring an equal number of measurements (TRs/condition). The specific mean duration was chosen to enhance detection of task-related differences in the blood oxygen level-dependent (BOLD) signal [<xref rid="pone.0288544.ref075" ref-type="bibr">75</xref>]. To mitigate potential confusion and eliminate mnemonic demands, a lower-case ‘c’ or ‘u’ was presented at the lower edge of the display throughout the anticipatory epoch. White-noise visual masks (3.2 s) were presented between trials to minimize persistence of the visual reinforcers in iconic memory. Subjects were periodically prompted (following the visual mask) to rate the intensity of fear/anxiety experienced a few seconds earlier, during the <italic toggle="yes">anticipation</italic> period of the prior trial, using a 1 (<italic toggle="yes">minimal</italic>) to 4 (<italic toggle="yes">maximal</italic>) scale and an MRI-compatible response pad (MRA, Washington, PA). Each condition was rated once per scan (16.7% trials). Skin conductance was continuously acquired throughout.</p>
                </sec>
                <sec sec-type="materials|methods" id="sec016">
                  <title>Procedures</title>
                  <p>Prior to fMRI scanning, participants practiced an abbreviated version of the MTC paradigm without electrical stimulation until staff confirmed understanding. Benign and aversive electrical stimulation levels were individually titrated. <italic toggle="yes">Benign Stimulation</italic>. Participants were asked whether they could “reliably detect” a 20 V stimulus and whether it was “at all unpleasant.” If the participant could not detect the stimulus, the voltage was increased by 4 V and the process repeated. If the participant indicated that the stimulus was unpleasant, the voltage was reduced by 4 V and the process was repeated. The final level chosen served as the benign electrical stimulation during the imaging assessment (<italic toggle="yes">M</italic> = 24.43 V, <italic toggle="yes">SD</italic> = 5.48 V). <italic toggle="yes">Aversive Stimulation</italic>. Participants received a 100 V stimulus and were asked whether it was “as unpleasant as you are willing to tolerate.” If the participant indicated that they were willing to tolerate more intense stimulation, the voltage was increased by 10 V and the process repeated. If the participant indicated that the stimulus was too intense, the voltage was reduced by 5 V and the process repeated. The final level chosen served as the aversive electrical stimulation during the imaging assessment (<italic toggle="yes">M</italic> = 121.33 V, <italic toggle="yes">SD</italic> = 45.14 V). Following each scan, staff verbally re-assessed whether the level of stimulation was sufficiently aversive and re-calibrated as necessary. Stimulation levels were similar to prior work in university samples [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>]. The groups did not significantly differ in the chosen intensity of benign or aversive electrical stimulation (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>).</p>
                </sec>
                <sec id="sec017">
                  <title>Electrical stimuli</title>
                  <p>Electrical stimuli (100 ms; 2 ms pulses every 10 ms) were generated using an MRI-compatible constant-voltage stimulator system (STMEPM-MRI; Biopac Systems, Inc., Goleta, CA). Stimuli were delivered using MRI-compatible, disposable carbon electrodes (Biopac) attached to the fourth and fifth digits of the non-dominant hand.</p>
                </sec>
                <sec id="sec018">
                  <title>Visual stimuli</title>
                  <p>Visual stimuli (1.8 s) were digitally back-projected (Powerlite Pro G5550, Epson America, Inc., Long Beach, CA) onto a semi-opaque screen mounted at the head-end of the scanner bore and viewed using a mirror mounted on the head-coil. A total of 72 aversive and benign photographs were selected from the International Affective Picture System [for details, see <xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>].</p>
                </sec>
                <sec id="sec019">
                  <title>Auditory stimuli</title>
                  <p>Auditory stimuli (0.80 s) were delivered using an amplifier (PA-1 Whirlwind) with in-line noise-reducing filters and ear buds (S14; Sensimetrics, Gloucester, MA) fitted with noise-reducing ear plugs (Hearing Components, Inc., St. Paul, MN). A total of 72 aversive and benign auditory stimuli were adapted from open-access online sources.</p>
                </sec>
                <sec id="sec020">
                  <title>Skin conductance data acquisition</title>
                  <p>Skin conductance was continuously acquired during each scan using a Biopac system (MP-150; Biopac Systems, Inc., Goleta, CA). Skin conductance (250 Hz; 0.05 Hz high-pass) was measured using MRI-compatible disposable electrodes (EL507) attached to the second and third digits of the non-dominant hand.</p>
                </sec>
                <sec id="sec021">
                  <title>MRI data acquisition</title>
                  <p>MRI data were acquired using a Siemens Magnetom TIM Trio 3 Tesla scanner (32-channel head-coil). Sagittal T1-weighted anatomical images were acquired using a magnetization prepared rapid acquisition gradient echo sequence (TR = 2,400 ms; TE = 2.01 ms; inversion time = 1,060 ms; flip angle = 8°; sagittal slice thickness = 0.8 mm; in-plane = 0.8 × 0.8 mm; matrix = 300 × 320; field-of-view = 240 × 256). A T2-weighted image was collected co-planar to the T1-weighted image (TR = 3,200 ms; TE = 564 ms; flip angle = 120°). To enhance resolution, a multi-band sequence was used to collect oblique-axial echo planar imaging (EPI) volumes (multiband acceleration = 6; TR = 1,250 ms; TE = 39.4 ms; flip angle = 36.4°; slice thickness = 2.2 mm, number of slices = 60; in-plane resolution = 2.1875 × 2.1875 mm; matrix = 96 × 96). Images were collected in the oblique axial plane (approximately −20° relative to the AC-PC plane) to minimize potential susceptibility artifacts. A total of three 478-volume EPI scans were acquired. The first seven volumes were automatically discarded by the scanner. To enable fieldmap correction, two oblique-axial spin echo (SE) images were collected in each of two opposing phase-encoding directions (rostral-to-caudal and caudal-to-rostral) at the same location and resolution as the functional volumes (i.e., co-planar; TR = 7,220 ms; TE = 73 ms).</p>
                </sec>
                <sec id="sec022">
                  <title>Skin conductance data pipeline</title>
                  <p>Skin conductance data were processed using <italic toggle="yes">PsPM</italic> (version 4.0.2) and in-house Matlab (version 9.9.0.1467703) code [<xref rid="pone.0288544.ref076" ref-type="bibr">76</xref>, <xref rid="pone.0288544.ref077" ref-type="bibr">77</xref>]. Data were regressed to remove pulse and respiration signals and de-spiked using <italic toggle="yes">filloutliers</italic> (150-sample moving-median widow; modified Akima cubic Hermite interpolation). Each scan was then band-pass filtered (0.009–0.333 Hz), median centered, and down-sampled (4 Hz). Participant-specific skin conductance response functions (SCRFs) were estimated by fitting the four parameters of the canonical SCRF [<xref rid="pone.0288544.ref078" ref-type="bibr">78</xref>] to the grand-average reinforcer response using <italic toggle="yes">fmincon</italic> and a cost function that maximized variance explained and penalized negative coefficients.</p>
                </sec>
                <sec id="sec023">
                  <title>MRI data pipeline</title>
                  <p>Methods were optimized to minimize spatial-normalization error and other potential sources of noise. Data were visually inspected before and after processing for quality assurance.</p>
                </sec>
                <sec id="sec024">
                  <title>Anatomical data processing</title>
                  <p>Methods are similar to those described in other recent reports by our group [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>]. T1-weighted images were inhomogeneity corrected using <italic toggle="yes">N4</italic> [<xref rid="pone.0288544.ref079" ref-type="bibr">79</xref>] and denoised using <italic toggle="yes">ANTS</italic> [<xref rid="pone.0288544.ref080" ref-type="bibr">80</xref>]. The brain was then extracted using <italic toggle="yes">BEaST</italic> [<xref rid="pone.0288544.ref081" ref-type="bibr">81</xref>] and brain-extracted and normalized reference brains from <italic toggle="yes">IXI</italic> [<xref rid="pone.0288544.ref082" ref-type="bibr">82</xref>]. Brain-extracted T1 images were normalized to a version of the brain-extracted 1-mm T1-weighted MNI152 (version 6) template [<xref rid="pone.0288544.ref083" ref-type="bibr">83</xref>] modified to remove extracerebral tissue. Normalization was performed using the diffeomorphic approach implemented in <italic toggle="yes">SyN</italic> (version 2.3.4) [<xref rid="pone.0288544.ref080" ref-type="bibr">80</xref>]. T2-weighted images were rigidly co-registered with the corresponding T1 prior to normalization. The brain extraction mask from the T1 was then applied. Tissue priors were unwarped to native space using the inverse of the diffeomorphic transformation [<xref rid="pone.0288544.ref084" ref-type="bibr">84</xref>]. Brain-extracted T1 and T2 images were segmented—using native-space priors generated in <italic toggle="yes">FAST</italic> (version 6.0.4) [<xref rid="pone.0288544.ref085" ref-type="bibr">85</xref>]—to enable T1-EPI co-registration (see below).</p>
                </sec>
                <sec id="sec025">
                  <title>Fieldmap data processing</title>
                  <p>SE images and <italic toggle="yes">topup</italic> were used to create fieldmaps. Fieldmaps were converted to radians, median-filtered, and smoothed (2-mm). The average of the distortion-corrected SE images was inhomogeneity corrected using <italic toggle="yes">N4</italic> and masked to remove extracerebral voxels using <italic toggle="yes">3dSkullStrip</italic> (version 19.1.00).</p>
                </sec>
                <sec id="sec026">
                  <title>Functional data processing</title>
                  <p>EPI files were de-spiked using <italic toggle="yes">3dDespike</italic>, slice-time corrected to the TR center using <italic toggle="yes">3dTshift</italic>, and motion corrected to the first volume and inhomogeneity corrected using <italic toggle="yes">ANTS</italic> (12-parameter affine). Transformations were saved in ITK-compatible format for subsequent use [<xref rid="pone.0288544.ref086" ref-type="bibr">86</xref>]. The first volume was extracted for EPI-T1 coregistration. The reference EPI volume was simultaneously co-registered with the corresponding T1-weighted image in native space and corrected for geometric distortions using boundary-based registration [<xref rid="pone.0288544.ref085" ref-type="bibr">85</xref>]. This step incorporated the previously created fieldmap, undistorted SE, T1, white matter (WM) image, and masks. The spatial transformations necessary to transform each EPI volume from native space to the reference EPI, from the reference EPI to the T1, and from the T1 to the template were concatenated and applied to the processed EPI data in a single step to minimize incidental spatial blurring. Normalized EPI data were resampled (2 mm<sup>3</sup>) using fifth-order b-splines. Hypothesis testing focused on anatomically defined regions of interest (ROIs), as detailed below. To maximize anatomical resolution, no additional spatial filters were applied, consistent with recent recommendations [<xref rid="pone.0288544.ref087" ref-type="bibr">87</xref>]. By convention, exploratory whole-brain voxelwise analyses employed data that were spatially smoothed (6-mm) using <italic toggle="yes">3DblurInMask</italic>.</p>
                </sec>
              </sec>
              <sec id="sec027">
                <title>Skin conductance data exclusions and modeling</title>
                <sec id="sec028">
                  <title>Data exclusions</title>
                  <p>Six participants were excluded from skin conductance analyses due to inadequate data quality, indicated by either staff observation at the time of data acquisition or non-positive mean responses to noxious stimulation.</p>
                </sec>
                <sec id="sec029">
                  <title>First-Level modeling</title>
                  <p>Robust general linear models (GLMs) were used to separate electrodermal signals associated with the anticipatory periods of the MTC paradigm from those evoked by other aspects of the task (e.g., reinforcer delivery). Modeling was performed separately for each participant and scan using <italic toggle="yes">robustfit</italic>. Subject-specific SCRFs were convolved with rectangular regressors time-locked to the presentation of the reinforcers (separately for each trial type), visual masks, and rating prompts. To quantify skin conductance level (SCL) during the anticipation (‘countdown’) epochs, first-level residuals were averaged separately for each participant and trial type.</p>
                </sec>
              </sec>
              <sec id="sec030">
                <title>fMRI data exclusions and modeling</title>
                <sec id="sec031">
                  <title>Data exclusions</title>
                  <p>Participants who responded to &lt;50% of rating prompts—indicating poor task compliance—were excluded from all analyses (<italic toggle="yes">n</italic> = 2). The remaining participants completed &gt;83% of the ratings (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>). Volume-to-volume displacement (&gt;0.5 mm) was used to assess residual motion artifact. Scans with excessively frequent artifacts (&gt;3 <italic toggle="yes">SD</italic>) were discarded. The remaining participants provided at least 2 scans of usable data.</p>
                </sec>
                <sec id="sec032">
                  <title>Canonical first-level modeling</title>
                  <p>Single-participant (‘first-level’) GLMs were used to separate hemodynamic signals associated with the anticipatory periods of the MTC paradigm from those evoked by other aspects of the task. GLMs were implemented in <italic toggle="yes">SPM12</italic> (version 7771) using the default autoregressive model and the temporal band-pass filter set to the hemodynamic response function (HRF) and 128 s [<xref rid="pone.0288544.ref088" ref-type="bibr">88</xref>]. Anticipatory signals were modeled using variable-duration rectangular regressors time-locked to the countdown periods of the Uncertain Threat, Certain Threat, and Uncertain Safety trials; and convolved with a canonical HRF and its temporal derivative. To maximize design efficiency, Certain Safety anticipation—which is psychologically similar to a conventional inter-trial interval—served as the implicit baseline. Periods corresponding to the presentation of the reinforcers (separately for each trial type), visual masks, and rating prompts were simultaneously modeled using the same approach. Consistent with prior work using the MTC paradigm [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>], nuisance variates included estimates of volume-to-volume displacement, motion (6 parameters × 3 lags), cerebrospinal fluid (CSF) signal, instantaneous pulse and respiration rates, and ICA-derived nuisance signals (e.g. brain edge, CSF edge, global motion, white matter) [<xref rid="pone.0288544.ref089" ref-type="bibr">89</xref>]. Volumes with excessive volume-to-volume displacement (&gt;0.5 mm) and those during and immediately following reinforcer delivery were censored.</p>
                </sec>
                <sec id="sec033">
                  <title>Extended amygdala regions of interest (ROIs)</title>
                  <p>Consistent with prior work by our group, task-related Ce and BST activation was quantified using well-established, anatomically defined ROIs and spatially unsmoothed fMRI data in atlas space [<xref rid="pone.0288544.ref087" ref-type="bibr">87</xref>] (<bold><xref rid="pone.0288544.g001" ref-type="fig">Fig 1</xref></bold>). The derivation of the Ce ROI is detailed in Tillman et al. (2018). The probabilistic BST ROI was developed by Theiss and colleagues and was thresholded at 25% [<xref rid="pone.0288544.ref090" ref-type="bibr">90</xref>]. It mostly encompasses the supra-commissural BST, given the difficulty of reliably discriminating the borders of regions below the anterior commissure in T1-weighted images [<xref rid="pone.0288544.ref091" ref-type="bibr">91</xref>]. Bilateral ROIs were decimated to the 2-mm resolution of the fMRI data. EAc ROI analyses used standardized regression coefficients extracted and averaged for each combination of task contrast (e.g., Uncertain Threat anticipation vs. Uncertain Safety anticipation), ROI, and participant. <italic toggle="yes">A priori</italic> anatomically defined ROIs provided unbiased estimates of brain-phenotype associations [i.e., statistically unbiased effect size estimates; <xref rid="pone.0288544.ref048" ref-type="bibr">48</xref>]. Key conclusions remained unchanged when Certain and Uncertain Threat were contrasted with the implicit baseline (Certain Safety anticipation; not reported).</p>
                </sec>
              </sec>
              <sec id="sec034">
                <title>Analytic strategy</title>
                <sec id="sec035">
                  <title>Overview</title>
                  <p>Except where noted otherwise, analyses were performed using <italic toggle="yes">R</italic> (version 4.0.2) [<xref rid="pone.0288544.ref092" ref-type="bibr">92</xref>] and <italic toggle="yes">RStudio</italic> [<xref rid="pone.0288544.ref093" ref-type="bibr">93</xref>]. Descriptive psychometric analyses were performed using <italic toggle="yes">psych</italic> (version 2.2.5) [<xref rid="pone.0288544.ref094" ref-type="bibr">94</xref>]. Some figures were created using <italic toggle="yes">ggpubr</italic> (version 0.4.0) [<xref rid="pone.0288544.ref095" ref-type="bibr">95</xref>] and MRIcron [<xref rid="pone.0288544.ref096" ref-type="bibr">96</xref>]. To facilitate interpretation, standardized effect sizes (Cohen’s <italic toggle="yes">d</italic>) were computed for key group mean differences using <italic toggle="yes">JASP</italic> (version 0.16.3) [<xref rid="pone.0288544.ref097" ref-type="bibr">97</xref>].</p>
                  <p>The overarching goal of this project was to perform a multimodal assessment of the impact of 24-hour nicotine abstinence, with a major focus on the consequences of acute abstinence for EAc threat reactivity. To that end, hypothesis testing focused on four measurement modalities (‘readouts’): <bold>(a)</bold> questionnaire measures of subjective smoking urges (BQSU) and withdrawal symptoms (WSWS), including anxious withdrawal (WSWS-Anxiety); <bold>(b)</bold> in-scanner ratings of subjective fear and anxiety elicited by threat anticipation; <bold>(c)</bold> concurrent measures of threat-evoked physiological arousal (SCL); and <bold>(d)</bold> and fMRI measures of EAc threat reactivity (Ce and BST ROIs; spatially unsmoothed data).</p>
                </sec>
                <sec id="sec036">
                  <title>Confirmatory testing</title>
                  <p>In combination with the breath CO assessment performed at the outset of the neuroimaging session (<bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>), the questionnaire measures of smoking urges and withdrawal served as a check on the validity of the abstinence manipulation, while the ratings and SCL measures served as a check on the validity of the threat-anticipation (MTC) paradigm [<xref rid="pone.0288544.ref098" ref-type="bibr">98</xref>, <xref rid="pone.0288544.ref099" ref-type="bibr">99</xref>]. As a further check, we confirmed that the MTC paradigm activated the canonical threat-anticipation network, including the dorsal amygdala (Ce) and BST [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0288544.ref100" ref-type="bibr">100</xref>]. Spatially smoothed data (6-mm kernel) and whole-brain voxelwise (‘second-level’) repeated-measures GLMs (‘random effects’) were used to compare each threat-anticipation condition with its corresponding control condition (e.g., Uncertain Threat vs. Uncertain Safety). Significance was assessed using FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected. As in prior work by our group [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>], a minimum conjunction test (logical ‘AND’) was used to identify voxels sensitive to both temporally Certain <italic toggle="yes">and</italic> Uncertain Threat anticipation [<xref rid="pone.0288544.ref101" ref-type="bibr">101</xref>]. Finally, a series of one-sample Student’s <italic toggle="yes">t</italic>-tests was used to confirm that the EAc ROIs—which capitalized on spatially unsmoothed data—showed significant activation during Certain and Uncertain Threat anticipation.</p>
                </sec>
                <sec id="sec037">
                  <title>Hypothesis testing</title>
                  <p>A series of independent Student’s <italic toggle="yes">t</italic>-tests were used to confirm the expectation that the 24-Hour Abstinence group would experience elevated smoking urges and withdrawal. Standard mixed-effects GLMs—implemented using <italic toggle="yes">afex</italic> (version 1.1–1)—were used to test whether acute abstinence potentiates subjective (fear/anxiety ratings) and objective psychophysiological (SCL) reactivity to the threat-anticipation paradigm [<xref rid="pone.0288544.ref102" ref-type="bibr">102</xref>]. Significant interactions (e.g., Group × Valence) were decomposed using focal independent or dependent Students <italic toggle="yes">t</italic>-tests. The same approach was used to test the central hypothesis that EAc threat reactivity would be potentiated in the 24-Hour Abstinence group, and to explore the possibility that hyper-reactivity would be more evident during Uncertain Threat anticipation [<xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>]. It merits comment that—because this analysis used contrasts (Uncertain Threat–Uncertain Safety; Certain Threat–Certain Safety)—the main effect of ‘ROI’ is conceptually and statistically equivalent to testing the Region × Valence interaction. On an exploratory basis, we also performed a series of whole-brain voxelwise GLMs to identify potential group differences in activation during Certain and Uncertain Threat anticipation (FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected). Sensitivity analyses indicated that none of the conclusions changed when mean-centered age was included as a nuisance variate (results not reported). Likewise, none of the conclusions drawn from the ROI analyses materially changed when we included mean-centered Ce/BST temporal signal-to-noise (tSNR)—an index of regional signal quality—as a nuisance variate (results not reported).</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="sec038">
              <title>Results</title>
              <sec id="sec039">
                <title>Acute nicotine abstinence increases smoking urges and withdrawal symptoms</title>
                <p>As shown in <bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold> and <bold><xref rid="pone.0288544.s001" ref-type="supplementary-material">S1 Fig</xref></bold>, the 24-Hour Abstinence group reported significantly greater smoking urges (BQSU), general withdrawal symptoms (WSWS), and anxious withdrawal (WSWS Anxiety) just prior to scanning, reinforcing the validity of our abstinence manipulation (<italic toggle="yes">t</italic>s(73)&gt;5.22, <italic toggle="yes">p</italic>s&lt;0.001, Cohen’s <italic toggle="yes">d</italic>s&gt;1.21).</p>
              </sec>
              <sec id="sec040">
                <title>Acute nicotine abstinence potentiates subjective reactivity to threat</title>
                <p>As shown in <bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2A</xref></bold>, fearful and anxious feelings were significantly elevated during the anticipation of Threat compared to Safety, and during the anticipation of temporally Uncertain compared to Certain reinforcers (Valence: <italic toggle="yes">F</italic>(1,73) = 108.73, <italic toggle="yes">p</italic>&lt;0.001; Certainty: <italic toggle="yes">F</italic>(1,73) = 32.53, <italic toggle="yes">p</italic>&lt;0.001).</p>
                <fig position="float" id="pone.0288544.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0288544.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>The impact of acute nicotine abstinence on subjective distress and objective physiological arousal elicited by the threat-anticipation paradigm.</title>
                    <p><italic toggle="yes">Upper panels</italic>. Mean self-reported intensity of fear and anxiety experienced during the anticipation epoch of each condition for the Smoke-as-Usual (<italic toggle="yes">grey</italic>) and 24-hour Abstinence (<italic toggle="yes">red</italic>) groups. Participants were quasi-randomly prompted to rate each condition three times while completing the MTC paradigm. <italic toggle="yes">Lower panels</italic>. Mean SCL during the anticipation epochs of the MTC. (a) Consistent with prior work, distress was significantly elevated during the anticipation of Threat compared to Safety, and during the anticipation of temporally Uncertain compared to Certain reinforcers (<italic toggle="yes">p</italic>s&lt;0.001). (b) The 24-Hour Abstinence group experienced significantly intensified fear and anxiety during the anticipation of Threat compared to Safety (Group × Valence, <italic toggle="yes">p</italic> = 0.002). (c) Psychophysiological arousal was also significantly increased during the anticipation of Threat compared to Safety, reinforcing the validity of the MTC paradigm (<italic toggle="yes">p</italic>&lt;0.001). This increase was particularly evident during the anticipation of temporally Uncertain compared to Certain reinforcers (Valence × Certainty, <italic toggle="yes">p</italic>&lt;0.001). On average, abstinent participants showed significantly greater arousal throughout the MTC paradigm (inclusive of all conditions) compared to those who smoked as usual (<italic toggle="yes">p</italic> = 0.008). (d) Echoing the subjective distress results, the 24-Hour Abstinence group showed a trend toward greater arousal during Threat anticipation (Group × Valence, <italic toggle="yes">p</italic> = 0.07). Bars indicate group means, whiskers indicate SEs, and dots indicate participant-level means.</p>
                  </caption>
                  <graphic xlink:href="pone.0288544.g002" position="float"/>
                </fig>
                <p>Notably, the 24-Hour Abstinent group reported significantly more intense fear and anxiety during Threat (vs. Safety) anticipation, compared to the Smoke-as-Usual group (Group × Valence: <italic toggle="yes">F</italic>(1,73) = 10.40, <italic toggle="yes">p</italic> = 0.002, Cohen’s <italic toggle="yes">d</italic> = 0.75; 24-Hour Abstinence, Threat vs. Safety: <italic toggle="yes">t</italic>(37) = 9.05, <italic toggle="yes">p</italic>&lt;0.001; Smoke-as-Usual, Threat vs. Safety: <italic toggle="yes">t</italic>(36) = 5.51, <italic toggle="yes">p</italic>&lt;0.001). The group difference in distress was numerically larger when threat was temporally uncertain, but this difference was not statistically significant (Group × Valence × Certainty, <italic toggle="yes">F</italic>(73) = 2.39, <italic toggle="yes">p</italic> = 0.13). Other effects were not significant, <italic toggle="yes">p</italic>s&gt;0.13. In short, acute nicotine abstinence amplifies threat-evoked distress, and does so similarly across Certain and Uncertain threat contexts (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2B</xref></bold>).</p>
              </sec>
              <sec id="sec041">
                <title>Acute nicotine abstinence non-specifically increases physiological arousal</title>
                <p>As shown in <bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2C</xref></bold>, SCL—an objective psychophysiological index of arousal—was significantly increased during the anticipation of Threat compared to Safety, and this was particularly evident during the anticipation of temporally Uncertain reinforcers (Valence: <italic toggle="yes">F</italic>(1,67) = 746.50, <italic toggle="yes">p</italic>&lt;0.001; Certainty: <italic toggle="yes">F</italic>(1,67) = 101.86, <italic toggle="yes">p</italic>&lt;0.001; Valence × Certainty: <italic toggle="yes">F</italic>(1,67) = 746.50, <italic toggle="yes">p</italic>&lt;0.001; Threat, Uncertain vs. Certain: <italic toggle="yes">t</italic>(68) = 12.72, <italic toggle="yes">p</italic>&lt;0.001; Safety, Uncertain vs. Certain: <italic toggle="yes">t</italic>(68) = -3.89, <italic toggle="yes">p</italic>&lt;0.001). These observations reinforce the validity of the MTC paradigm as an experimental probe of fear and anxiety.</p>
                <p>Averaged <italic toggle="yes">across</italic> conditions of the MTC paradigm, abstinent smokers showed significantly greater physiological arousal than those who smoked as usual (<italic toggle="yes">F</italic>(1,67) = 7.56, <italic toggle="yes">p</italic> = 0.008, Cohen’s <italic toggle="yes">d</italic> = 0.66). Echoing the results for subjective distress, the 24-Hour Abstinence group also showed a trend toward greater arousal during Threat anticipation (Group × Valence: <italic toggle="yes">F</italic>(1,67) = 2.59, <italic toggle="yes">p</italic> = 0.071, Cohen’s <italic toggle="yes">d</italic> = 0.44; 24-Hour Abstinence, Threat vs. Safety: <italic toggle="yes">t</italic>(34) = 20.52, <italic toggle="yes">p</italic>&lt;0.001; Smoke-as-Usual, Threat vs. Safety: <italic toggle="yes">t</italic>(33) = 18.13, <italic toggle="yes">p</italic>&lt;0.001). The group difference in arousal was numerically larger when threat was temporally uncertain, but this difference was not statistically significant (Group × Valence × Certainty, <italic toggle="yes">F</italic>(67) = 2.59, <italic toggle="yes">p</italic> = 0.11). Other effects were not significant, <italic toggle="yes">p</italic>s&gt;0.10. Collectively, these observations show that acute nicotine abstinence non-specifically increases physiological arousal during periods of threat and safety anticipation (red vs. gray bars, <bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2C</xref></bold>), and provide weak convergent evidence of potentiated reactivity to threat (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2D</xref></bold>).</p>
              </sec>
              <sec id="sec042">
                <title>The MTC paradigm recruits the canonical threat-anticipation network, including the EAc</title>
                <p>We used a series of whole-brain voxelwise GLMs to determine whether that the MTC paradigm had the intended consequences on brain function. As expected, Uncertain Threat anticipation was associated with significant activation across a widely distributed network of regions previously implicated in the expression and regulation of human fear and anxiety [<xref rid="pone.0288544.ref100" ref-type="bibr">100</xref>], including the midcingulate cortex (MCC); anterior insula (AI) extending into the frontal operculum (FrO); dorsolateral prefrontal cortex (dlPFC) extending to the frontal pole (FP); brainstem encompassing the periaqueductal grey (PAG); basal forebrain, in the region of the BST; and dorsal amygdala (Uncertain Threat &gt; Uncertain Safety; FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected; <bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold> and <bold><xref rid="pone.0288544.s004" ref-type="supplementary-material">S3</xref> and <xref rid="pone.0288544.s005" ref-type="supplementary-material">S4</xref> Tables</bold>).</p>
                <fig position="float" id="pone.0288544.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0288544.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>Uncertain and Certain Threat anticipation recruit a common cortico-subcortical network.</title>
                    <p>Key regions (<italic toggle="yes">cyan arrowheads</italic>) show significantly increased activation during the anticipation of both Uncertain Threat (<italic toggle="yes">left column</italic>) and Certain Threat (<italic toggle="yes">middle column</italic>) compared to their respective control conditions (FDR <italic toggle="yes">q</italic>&lt;0.05, whole-brain corrected). Both threat conditions recruited a common neural circuit—including the BST and dorsal amygdala (Ce)—replicating prior work in university students [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>]. <italic toggle="yes">Right column</italic> depicts the voxelwise overlap (Logical AND of the thresholded maps depicted in the left and middle columns). BST and dorsal amygdala images are masked to highlight the extended amygdala. Coronal insets show the corresponding statistical parametric maps without the extended amygdala mask. Abbreviations—Ant., anterior; dlPFC, Dorsolateral Prefrontal Cortex; FrO, Frontal Operculum; BST, Bed Nucleus of the Stria Terminalis; FDR, False discovery rate; PAG, Periaqueductal Gray; WB, whole-brain corrected.</p>
                  </caption>
                  <graphic xlink:href="pone.0288544.g003" position="float"/>
                </fig>
                <p>We used a parallel approach to identify regions recruited during the anticipation of temporally Certain Threat (Certain Threat &gt; Certain Safety; FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected). As shown in the middle column of <bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold>, results were notably similar to those evident during Uncertain Threat anticipation (<bold><xref rid="pone.0288544.s006" ref-type="supplementary-material">S5</xref>, <xref rid="pone.0288544.s007" ref-type="supplementary-material">S6</xref> Tables</bold>). In fact, as shown in the right column of <bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold>, a minimum conjunction analysis [Logical ‘AND;’ 101] revealed voxelwise co-localization in every key cortical and subcortical region, including the BST and dorsal amygdala in the region of the Ce (<bold><xref rid="pone.0288544.s008" ref-type="supplementary-material">S7 Table</xref></bold>). These observations replicate prior work in university samples, confirm that the MTC paradigm robustly engages the canonical threat anticipation network—including the EAc—and set the stage for testing the impact of acute nicotine abstinence on EAc threat reactivity [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref043" ref-type="bibr">43</xref>].</p>
              </sec>
              <sec id="sec043">
                <title>Acute nicotine abstinence had a negligible impact on EAc threat reactivity</title>
                <p>We leveraged anatomically defined Ce and BST ROIs and spatially unsmoothed fMRI data to rigorously test the prediction that acute nicotine abstinence amplifies EAc reactivity to threat, and to explore the possibility that amplification would be more evident during Uncertain Threat anticipation (<bold><xref rid="pone.0288544.g001" ref-type="fig">Fig 1</xref></bold>). As a precursor to hypothesis testing, we used a series of <italic toggle="yes">t</italic>-tests to confirm that the Ce and BST ROIs exhibit significant activation during the anticipation of Certain and Uncertain Threat, relative to their respective control conditions (<bold><xref rid="pone.0288544.g004" ref-type="fig">Fig 4</xref></bold>). Consistent with the voxelwise results (<bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold>), both ROIs were significantly recruited by both kinds of Threat, <italic toggle="yes">t</italic>s(75)&gt;2.22, <italic toggle="yes">p</italic>s&lt;0.03 (<bold><xref rid="pone.0288544.s009" ref-type="supplementary-material">S8 Table</xref></bold>). We then used a standard mixed-effects GLM for hypothesis testing. As shown in <bold><xref rid="pone.0288544.g004" ref-type="fig">Fig 4</xref></bold>, results revealed the BST was significantly more sensitive to threat anticipation—irrespective of threat certainty—compared to the Ce (Region: <italic toggle="yes">F</italic>(1,73) = 9.27, <italic toggle="yes">p</italic> = 0.003). On average, the EAc showed significantly greater activation during the anticipation of temporally Uncertain Threat (Threat Certainty: <italic toggle="yes">F</italic>(1,73) = 5.39, <italic toggle="yes">p</italic> = 0.02). Interpretation of these effects is somewhat tempered by a trend-level Region × Threat Certainty interaction (<italic toggle="yes">F</italic>(73) = 2.80, <italic toggle="yes">p</italic> = 0.10). Focal comparisons indicated that that the Ce showed an indiscriminate pattern of reactivity, with statistically indistinguishable levels of heightened activation during the anticipation of Certain and Uncertain Threat (<italic toggle="yes">t</italic>(74) = 0.65, <italic toggle="yes">p</italic> = 0.52). In contrast, the BST showed a more pronounced preference for responding to Uncertain Threat anticipation (<italic toggle="yes">t</italic>(74) = 2.80, <italic toggle="yes">p</italic> = 0.007). No other GLM effects were significant (<italic toggle="yes">p</italic>s&gt;0.33), indicating that acute nicotine abstinence had a negligible impact on EAc threat reactivity, contrary to prediction. Although the 24-Hour Abstinence group did show numerically greater EAc activation during threat anticipation, as hypothesized, the standardized group differences were non-significant (<italic toggle="yes">t</italic>s(73)&lt;0.03 <italic toggle="yes">p</italic>s&gt;0.64) and very small to nil (Cohen’s <italic toggle="yes">d</italic>s: Ce = 0.009, BST = 0.11, EAc Average = 0.08; <bold><xref rid="pone.0288544.g005" ref-type="fig">Fig 5</xref></bold>). Likewise, exploratory whole-brain voxelwise analyses did not uncover any regions showing significant nicotine abstinence effects for either Certain or Uncertain Threat (FDR <italic toggle="yes">q</italic>&lt;0.05, whole-brain corrected), perhaps reflecting the highly distributed neural substrates of subjective distress [<xref rid="pone.0288544.ref103" ref-type="bibr">103</xref>, <xref rid="pone.0288544.ref104" ref-type="bibr">104</xref>].</p>
                <fig position="float" id="pone.0288544.g004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0288544.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>The impact of threat anticipation and acute nicotine abstinence on the EAc.</title>
                    <p>Figure depicts mean contrast coefficients (Threat—Safety) during the anticipation of temporally Certain or Uncertain Threat—relative to their respective control conditions—in the anatomically defined Ce (<italic toggle="yes">yellow</italic>) and BST (<italic toggle="yes">magenta</italic>) ROIs for the Smoke-as-Usual (<italic toggle="yes">grey</italic>) and 24-hour Abstinence (<italic toggle="yes">red</italic>) groups. The BST was more sensitive to threat—irrespective of temporal certainty—compared to the Ce (<italic toggle="yes">p</italic> = 0.003). On average, the two divisions of the EAc showed greater activation during Uncertain Threat anticipation (<italic toggle="yes">p</italic> = 0.02). Interpretation of these effects is tempered by a trend-level Region × Threat Certainty interaction (<italic toggle="yes">p</italic> = 0.10). The Ce showed similarly heightened activation during Certain and Uncertain Threat anticipation (<italic toggle="yes">p</italic> = 0.52), whereas the BST showed a clear preference for Uncertain Threat (<italic toggle="yes">p</italic> = 0.007). Other effects were nonsignificant (<italic toggle="yes">p</italic>s&gt;0.33), indicating that acute nicotine abstinence had a negligible impact on EAC threat reactivity. Bars indicate group means, whiskers indicate SEs, and dots indicate participant-level means. Abbreviations—BST, bed nucleus of the stria terminalis; Ce, central nucleus of the amygdala; ROI, region of interest.</p>
                  </caption>
                  <graphic xlink:href="pone.0288544.g004" position="float"/>
                </fig>
                <fig position="float" id="pone.0288544.g005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0288544.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>Forest plot summarizing the consequences of acute nicotine abstinence across key outcomes.</title>
                    <p>To facilitate comparison, results are depicted as standardized group mean differences (<italic toggle="yes">dots</italic>; Cohen’s <italic toggle="yes">d</italic>). Whiskers indicate the precision of the standardized differences (95% confidence interval). <italic toggle="yes">Upper panel</italic> (<italic toggle="yes">light grey</italic>) shows group differences for subjective feelings of smoking urgency and withdrawal, both assessed just prior to scanning. <italic toggle="yes">Lower panel</italic> (<italic toggle="yes">dark grey</italic>) shows standardized group differences for the threat-reactivity (Threat minus Safety) measures acquired during fMRI scanning, including threat-evoked changes in subjective fear and anxiety, objective physiological arousal (SCL), and EAc activation. While all of the standardized group differences were in the expected positive direction (24-Hour Abstinence &gt; Smoke-as-Usual), there were marked differences in magnitude across outcomes. Nicotine abstinence exerted a large to very large (<italic toggle="yes">red</italic>) impact on all of the self-report measures of subjective experience (<italic toggle="yes">d</italic>s = 0.75–2.33). In contrast, nicotine abstinence exerted a more moderate influence on threat-elicited arousal (<italic toggle="yes">green</italic>; <italic toggle="yes">d</italic> = 0.44) and a very small to nil impact on the fMRI measures of EAc threat reactivity (<italic toggle="yes">blue</italic>; <italic toggle="yes">d</italic>s = 0.01–0.11). Effect sizes are interpreted with reference to widely used benchmarks (<italic toggle="yes">Large</italic>, <italic toggle="yes">d</italic> = 0.80; <italic toggle="yes">Medium</italic>, <italic toggle="yes">d</italic> = 0.50; <italic toggle="yes">Small</italic>, <italic toggle="yes">d</italic> = 0.20) [<xref rid="pone.0288544.ref138" ref-type="bibr">138</xref>]. Abbreviations—BST, bed nucleus of the stria terminalis; Ce, central nucleus of the amygdala; CI, confidence interval; EAc, central extended amygdala; fMRI, functional magnetic resonance imaging.</p>
                  </caption>
                  <graphic xlink:href="pone.0288544.g005" position="float"/>
                </fig>
              </sec>
              <sec id="sec044">
                <title>Different modalities provide unique perspectives on the impact of acute nicotine abstinence</title>
                <p>The overarching goal of this project was to develop a more complete understanding of the psychobiological impact of acute nicotine abstinence and, to that end, we acquired a multimodal battery of subjective (questionnaires and ratings) and objective (skin conductance and fMRI) measures. A natural question concerns the degree to which those ‘readouts’ reflect a single or small number of latent states (e.g., ‘abstinence’ or ‘anxiety’). Do subjective reports of threat-elicited distress covary with objective signs of physiological arousal, for instance? Does BST threat reactivity covary with individual differences in the subjective intensity of smoking urges? To address these questions and inform the interpretation of our primary hypothesis tests, we computed Spearman correlations across all of the measures acquired at the neuroimaging session, both for the entire sample and for the 24-Hour Abstinence group (<bold><xref rid="pone.0288544.s010" ref-type="supplementary-material">S9</xref> and <xref rid="pone.0288544.s011" ref-type="supplementary-material">S10</xref> Tables</bold>). While we detected numerous nominally significant associations, on balance, the four measurement modalities showed a relatively weak and inconsistent pattern of covariance, in broad accord with work underscoring the modest coherence (‘concordance’ or ‘synchrony’) of emotion readouts [<xref rid="pone.0288544.ref105" ref-type="bibr">105</xref>, <xref rid="pone.0288544.ref106" ref-type="bibr">106</xref>]. In sum, each of the four measurement modalities acquired here provides a distinct and relatively independent perspective on the consequences of acute nicotine abstinence.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec045">
              <title>Discussion</title>
              <p>Tobacco smoking imposes a staggering burden on global public health [<xref rid="pone.0288544.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>]. Relapse is common and existing cessation aids are far from curative, underscoring the urgency of developing a fuller understanding of the consequences of acute nicotine abstinence and withdrawal [<xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0288544.ref107" ref-type="bibr">107</xref>, <xref rid="pone.0288544.ref108" ref-type="bibr">108</xref>]. Converging lines of clinical and experience sampling research highlight the importance of anxious withdrawal symptoms and negative reinforcement mechanisms for maintaining tobacco use in humans, but the underlying neurobiology has remained elusive, impeding therapeutics development [<xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0288544.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0288544.ref015" ref-type="bibr">15</xref>]. Mechanistic work in animals suggests that anxious withdrawal reflects neuroplastic alterations in EAc neurotransmission that promote exaggerated stressor reactivity in nicotine-dependent rats and mice, but the translational relevance of these discoveries to the complexities of the human brain and human emotion remain unclear [<xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0288544.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0288544.ref010" ref-type="bibr">10</xref>]. Here we leveraged a novel combination of subjective, psychophysiological, and neurobiological approaches to understand the impact of 24-hour nicotine abstinence in daily tobacco smokers (<bold><xref rid="pone.0288544.g001" ref-type="fig">Fig 1</xref></bold>). Results demonstrated that the abstinence manipulation worked as intended, potently increasing smoking urges and subjective symptoms of withdrawal, including anxious mood (<bold><xref rid="pone.0288544.s001" ref-type="supplementary-material">S1 Fig</xref></bold>). The threat-anticipation paradigm also had the expected consequences, amplifying subjective and somatic reactivity to threat, and recruiting the canonical threat-anticipation network, including the BST and dorsal amygdala (Ce) (<bold>Figs <xref rid="pone.0288544.g002" ref-type="fig">2</xref>–<xref rid="pone.0288544.g004" ref-type="fig">4</xref></bold>).</p>
              <p>Acute abstinence had robust consequences for subjective responses to the threat-anticipation paradigm, amplifying the intensity of threat-evoked fear and anxiety (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2B</xref></bold>). A similar trend (<italic toggle="yes">p</italic> = 0.07) was evident for threat-evoked arousal (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2D</xref></bold>). Acute abstinence was also associated with a tonic increase in arousal across the experimental threat and safety contexts (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2C</xref></bold>). Across these two measures, the magnitude of abstinence-induced increases in threat reactivity was similar across certain and uncertain contexts, suggesting less specificity than that observed in some prior psychophysiological studies [<xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>]. Although the 24-Hour Abstinence group did show numerically greater EAc activation in the threat contexts, as hypothesized, standardized group differences were negligible and whole-brain analyses did not uncover any other regions showing significant abstinence effects (<bold><xref rid="pone.0288544.g004" ref-type="fig">Fig 4</xref></bold>). Across ‘readouts’, acute abstinence showed a large to very large impact on all of the self-report measures of subjective experience, including tonic measures of smoking urges and withdrawal, and reactive measures of threat-elicited distress. In contrast, abstinence exerted a moderate influence on threat-elicited arousal, and a very small to nil impact on fMRI measures of EAc threat reactivity (<bold><xref rid="pone.0288544.g005" ref-type="fig">Fig 5</xref></bold>). Follow-up analyses revealed weak coherence across measures, suggesting that they provide comparatively independent perspectives on the consequences of acute nicotine abstinence (<bold><xref rid="pone.0288544.s010" ref-type="supplementary-material">S9</xref> and <xref rid="pone.0288544.s011" ref-type="supplementary-material">S10</xref> Tables</bold>). Collectively, these new observations provide a framework for conceptualizing the impact of acute nicotine abstinence and anxious withdrawal, with implications for basic, translational, and clinical science.</p>
              <p>Clinical, observational (e.g. EMA), experimental, and animal behavioral data suggest that withdrawal-related negative affect and heightened stressor reactivity are key triggers of lapses during nicotine cessation attempts [<xref rid="pone.0288544.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0288544.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0288544.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0288544.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0288544.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0288544.ref030" ref-type="bibr">30</xref>]. The present results reinforce this hypothesis. Leveraging a randomized study design, well-matched groups, and a potent experimental stressor, we observed robust increases in threat-evoked fear and anxiety (<bold>Figs <xref rid="pone.0288544.g001" ref-type="fig">1</xref>, <xref rid="pone.0288544.g002" ref-type="fig">2</xref> and <xref rid="pone.0288544.g005" ref-type="fig">5</xref></bold>; <bold><xref rid="pone.0288544.t001" ref-type="table">Table 1</xref></bold>). Our approach—which leveraged near-real-time ratings collected on a random subset of trials—circumvents the recall biases that can influence retrospective (end-of-task or end-of-session) assessments. Skin conductance evinced a parallel trend, tempering potential concerns centered on demand characteristics. Taken together, this body of work reinforces the significance of withdrawal-related anxiety and heightened stressor reactivity, and points to the need to develop cessation interventions that more effectively dampen stressor reactivity [<xref rid="pone.0288544.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0288544.ref109" ref-type="bibr">109</xref>–<xref rid="pone.0288544.ref111" ref-type="bibr">111</xref>]. Psychosocial treatments aimed at cultivating stronger emotion regulation skills or weakening the link between distress and smoking may be especially useful [<xref rid="pone.0288544.ref002" ref-type="bibr">2</xref>].</p>
              <p>Work in rodents suggests that the pervasive increases in anxiety (tonic) and heightened surges of stressor-evoked distress (reactive) that often accompany periods of abstinence in nicotine-dependent humans reflect hyper-reactivity to threat in the EAc [<xref rid="pone.0288544.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0288544.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0288544.ref010" ref-type="bibr">10</xref>]. Yet our unbiased ROI results show that the impact of 24-hour nicotine abstinence on EAc threat reactivity is negligible and largely unrelated to the subjective symptoms—the elevated smoking urges, withdrawal symptoms, and stressor-evoked distress—thought to maintain addiction in human smokers (<bold>Figs <xref rid="pone.0288544.g004" ref-type="fig">4</xref>, <xref rid="pone.0288544.g005" ref-type="fig">5</xref></bold> and <bold><xref rid="pone.0288544.s010" ref-type="supplementary-material">S9</xref> and <xref rid="pone.0288544.s011" ref-type="supplementary-material">S10</xref> Tables</bold>).</p>
              <p>How should we interpret this apparent failure of translation? One possibility is that the mechanistic insights gleaned from animal models of nicotine dependence are fundamentally correct, but conventional fMRI approaches—which rely on bulk changes in regional blood oxygenation—are insufficiently sensitive to underlying alterations in EAc molecular signaling and neuronal function [<xref rid="pone.0288544.ref112" ref-type="bibr">112</xref>]. Or, it might be that the threat-anticipation paradigm used here and in prior human psychophysiology studies is suboptimal (“wrong” human assay). Most of the anxiety assays used in rodent models of addiction—conditioned-place avoidance, elevated-plus maze, open field, shock-probe burying—focus on instrumental defensive behaviors emitted over extended assessment periods (5–15 minutes) [<xref rid="pone.0288544.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0288544.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0288544.ref113" ref-type="bibr">113</xref>–<xref rid="pone.0288544.ref115" ref-type="bibr">115</xref>]. In contrast, the Maryland Threat Countdown and other popular threat-anticipation assays (e.g., NPU, Pavlovian threat conditioning) are structured as randomly intermixed, relatively brief (5–90 s) periods of safety and threat [<xref rid="pone.0288544.ref064" ref-type="bibr">64</xref>, <xref rid="pone.0288544.ref116" ref-type="bibr">116</xref>]. To the extent that nicotine abstinence causes persistent, comparatively sluggish alterations in EAc threat reactivity—as one might expect based on the temporal dynamics of stress- and deprivation-induced changes in EAc neurotransmission [e.g., <xref rid="pone.0288544.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0288544.ref117" ref-type="bibr">117</xref>]—such ‘event-related’ repeated-measures designs may be suboptimal for detecting neural signs of threat hyper-reactivity. This speculation is consistent with the robust non-specific increase in somatic arousal that we observed in the 24-hour Abstinence group (<bold><xref rid="pone.0288544.g002" ref-type="fig">Fig 2C</xref></bold>). It is also consistent with the results of the only startle study that employed a between-subjects design. In a seminal 2010 report, Hogle and colleagues demonstrated that 24-hour nicotine abstinence magnified startle reactivity during a ~10-min block of temporally uncertain threat (shock), but was without effect in an independent sample of deprived smokers exposed to an intermixed block of certain-threat and certain-safety cues [<xref rid="pone.0288544.ref031" ref-type="bibr">31</xref>]. Although conventional fMRI sequences cannot quantify minutes-long changes in neural activity, recently established multiband perfusion (‘arterial spin labeling’) MRI sequences can do so with adequate anatomical resolution (&lt;3-mm<sup>3</sup>). Paired with a slow block-related design (e.g., 5-min baseline, 5-min uncertain threat, 5-min recovery), this approach would afford the opportunity to examine abstinence-induced alterations in tonic, reactive, and persistent (‘spill-over’) EAc activity. It would also afford the opportunity to explore stressors that more closely resemble those evident in real-world settings (e.g., social stressors). While we cannot rule out the possibility that the structure of our threat-anticipation paradigm is suboptimal for gauging the impact of nicotine abstinence on EAc function, the medium-to-large effects evident for stressor-potentiated distress and arousal (Valence and Group × Valence effects), and the robust impact on EAc activation across the two groups, run counter to this argument (<bold>Figs <xref rid="pone.0288544.g002" ref-type="fig">2</xref> and <xref rid="pone.0288544.g003" ref-type="fig">3</xref></bold>).</p>
              <p>Another possibility is that our results represent a genuine translation failure; that the neurobiological mechanisms identified in rodents are sound, but that shock-probe burying and other instrumental defensive behaviors are a suboptimal means of modeling the subjective feelings of anxiety and distress that are central to withdrawal and relapse among abstinent human smokers (“wrong” animal assay). We are not the first commentators to raise this concern [<xref rid="pone.0288544.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0288544.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0288544.ref106" ref-type="bibr">106</xref>, <xref rid="pone.0288544.ref118" ref-type="bibr">118</xref>]. It is broadly consistent with both the comparatively weak coherence that we observed across readouts and with the failure of several novel therapeutic compounds—which emerged from rodent models of anxiety and addiction—to show efficacy in human clinical and experimental-therapeutics trials [<xref rid="pone.0288544.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0288544.ref045" ref-type="bibr">45</xref>, <xref rid="pone.0288544.ref119" ref-type="bibr">119</xref>]. For example, corticotropin-releasing hormone (receptor 1) antagonists have been shown to <italic toggle="yes">exacerbate</italic> subjective anxiety elicited by a social stressor (Trier Social Stress Task) and <italic toggle="yes">potentiate</italic> startle reactivity to certain-and-imminent shock delivery, despite evidence of <italic toggle="yes">reduced</italic> amygdala glucose metabolism and <italic toggle="yes">blunted</italic> amygdala reactivity to emotional faces [<xref rid="pone.0288544.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0288544.ref120" ref-type="bibr">120</xref>, <xref rid="pone.0288544.ref121" ref-type="bibr">121</xref>]. On balance, these considerations underscore the need to develop coordinated cross-species models of abstinence-induced anxiety. An optimal translational model of withdrawal-induced anxiety would rely on broadly similar procedures across species (e.g., 5–10 min exposure to temporally uncertain shock), show similar behavioral signals across species (e.g., deprivation-induced startle potentiation), show evidence of behavioral relevance across species (e.g., associations with consumption, reinstatement, or lapses), show evidence of experiential relevance in humans (e.g., heightened symptoms of anxious withdrawal and craving), and be amenable to functional neuroimaging in both species (e.g., perfusion fMRI). Demonstrating consistent effects across rodent strains or species would further enhance confidence in translational relevance [<xref rid="pone.0288544.ref122" ref-type="bibr">122</xref>, <xref rid="pone.0288544.ref123" ref-type="bibr">123</xref>]. Preclinical studies of anxiety in nonhuman primates underscore the feasibility and added-value of this approach [<xref rid="pone.0288544.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0288544.ref124" ref-type="bibr">124</xref>, <xref rid="pone.0288544.ref125" ref-type="bibr">125</xref>].</p>
              <p>A final possibility is that we simply lack the power to detect modest abstinence-induced changes in EAc threat reactivity. As detailed in the Method, our study was powered to detect medium-to-large effects (Cohen’s <italic toggle="yes">d</italic>&gt;0.66). Inspection of the 95% confidence intervals shown in <bold><xref rid="pone.0288544.g005" ref-type="fig">Fig 5</xref></bold> raise the possibility that the true impact of acute nicotine abstinence on EAc threat reactivity (as indexed using the present approach) could plausibly be as large as <italic toggle="yes">d</italic> = .50 (‘medium’ effect). Reliably detecting an effect of this magnitude would require ~120 usable datasets. Even under this optimistic scenario, the distribution of EAc threat reactivity would massively (80.3%) overlap across the groups [<xref rid="pone.0288544.ref126" ref-type="bibr">126</xref>]. Put another way, with a medium-sized effect there is only a 63.8% chance that an individual picked at random from the 24-hour Abstinent group would show greater EAc threat reactivity than one picked at random from the Smoke-as-Usual group [<xref rid="pone.0288544.ref126" ref-type="bibr">126</xref>]. These statistical considerations make it unlikely that EAc threat reactivity—at least as indexed using the present neuroimaging approach—could be used as a biomarker of acute nicotine abstinence [<xref rid="pone.0288544.ref127" ref-type="bibr">127</xref>]. It lacks the sensitivity and specificity necessary for practical applications [<xref rid="pone.0288544.ref128" ref-type="bibr">128</xref>].</p>
              <p>While not the primary aim of the present project, our neuroimaging findings also shed light on the neurobiology of fear and anxiety. Since the time of Freud, the distinction between certain (‘fear’) and uncertain (‘anxiety’) danger has been a key feature of neuropsychiatric models of emotion—including the National Institute of Mental Health’s influential Research Domain Criteria (RDoC) framework—but the architecture of the underlying neural systems has remained contentious [<xref rid="pone.0288544.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0288544.ref051" ref-type="bibr">51</xref>–<xref rid="pone.0288544.ref057" ref-type="bibr">57</xref>]. Our whole-brain voxelwise results demonstrate that uncertain-threat anticipation recruits a distributed network of fronto-cortical (MCC, AI/FrO, and dlPFC/FP) and subcortical (PAG, BST, and dorsal amygdala) regions (<bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold>). Analyses focused on the anticipation of temporally certain threat revealed a similar pattern, with voxels sensitive to both kinds of threat evident across these key regions (<bold><xref rid="pone.0288544.g003" ref-type="fig">Fig 3</xref></bold>). These observations dovetail with recent meta-analyses of the neuroimaging literature, replicate prior evidence of anatomical co-location in university students, and reinforce the conclusion that ‘fear’ and ‘anxiety’ reflect a shared set of neural building blocks [<xref rid="pone.0288544.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0288544.ref129" ref-type="bibr">129</xref>, <xref rid="pone.0288544.ref130" ref-type="bibr">130</xref>].</p>
              <p>Our results also have implications for on-going debates about the functional architecture of the EAc [<xref rid="pone.0288544.ref034" ref-type="bibr">34</xref>]. Inspired by an earlier-generation of lesion studies in rodents [<xref rid="pone.0288544.ref131" ref-type="bibr">131</xref>], it is widely believed that these regions are functionally dissociable, with the amygdala mediating phasic responses to clear-and-immediate danger (‘fear’) and the BST mediating sustained responses to uncertain-or-remote danger (‘anxiety’) [<xref rid="pone.0288544.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0288544.ref132" ref-type="bibr">132</xref>–<xref rid="pone.0288544.ref134" ref-type="bibr">134</xref>]. This hypothesized double dissociation has even been enshrined in the RDoC framework [<xref rid="pone.0288544.ref056" ref-type="bibr">56</xref>, <xref rid="pone.0288544.ref135" ref-type="bibr">135</xref>, <xref rid="pone.0288544.ref136" ref-type="bibr">136</xref>]. Leveraging the enhanced resolution afforded by a best-practices fMRI pipeline and spatially unsmoothed data, our unbiased ROI results demonstrate that the Ce and the BST both show significant engagement across threat contexts, consistent with our voxelwise observations (<bold>Figs <xref rid="pone.0288544.g003" ref-type="fig">3</xref> and <xref rid="pone.0288544.g004" ref-type="fig">4</xref>; <xref rid="pone.0288544.s009" ref-type="supplementary-material">S8 Table</xref></bold>). On average, the EAc showed significantly greater activation during the anticipation of temporally uncertain threat, paralleling the concurrent measures of subjective distress and objective arousal (<bold>Figs <xref rid="pone.0288544.g002" ref-type="fig">2</xref> and <xref rid="pone.0288544.g004" ref-type="fig">4</xref></bold>). While the Region × Threat Certainty interaction was only marginally significant (<italic toggle="yes">p</italic> = 0.10), focal comparisons indicated that that the Ce showed an indiscriminate pattern of reactivity, with statistically indistinguishable levels of heightened activation during the anticipation of certain and uncertain threat. In contrast, the BST showed preferential activation during the anticipation of uncertain threat, consistent with a recent large-scale (<italic toggle="yes">n</italic> = 109) study that employed anatomical ROIs [<xref rid="pone.0288544.ref137" ref-type="bibr">137</xref>]. These observations are broadly consistent with the influential model of Davis and colleagues—which suggests that the Ce is involved in responding to both kinds of threat—but run counter to the popular double dissociation model (Ce: Certain &gt;&gt; Uncertain ≈ 0; BST: 0 ≈ Certain &lt;&lt; Uncertain) [<xref rid="pone.0288544.ref051" ref-type="bibr">51</xref>]. While our understanding remains far from complete, this body of observations underscores the need to reformulate RDoC and other models of fear and anxiety that imply a strict segregation of certain and uncertain threat processing in the EAc.</p>
              <p>Tobacco smoking is a leading preventable cause of morbidity and mortality, and converging lines of evidence underscore the relevance of abstinence-induced anxiety and negative reinforcement mechanisms to the maintenance and treatment of nicotine use. Our experimental results reinforce and extend claims—made largely made on the basis of observational data—that acute nicotine abstinence triggers persistent increases in anxious mood and potentiates subjective stressor reactivity. Our neuroimaging results demonstrate that the impact of acute abstinence on EAc threat reactivity is negligible in humans, raising questions about the translational relevance of popular animal and human experimental models of addiction. A key challenge for the future will be to establish coordinated cross-species models of anxiety and addiction (bi-directional translation). A comprehensive multidimensional approach, well-established threat-anticipation task, and best-practice approaches to data acquisition, processing, and analysis enhance confidence in the robustness and translational relevance of our results. These observations provide a novel framework for conceptualizing anxious withdrawal symptoms and negative reinforcement mechanisms and for accelerating the development of more effective treatment strategies for nicotine dependence.</p>
            </sec>
            <sec id="sec046" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0288544.s001" position="float" content-type="local-data">
                <label>S1 Fig</label>
                <caption>
                  <p>The impact of acute nicotine abstinence on mean self-reported <bold>(a)</bold> smoking urges, <bold>(b)</bold> general withdrawal, and <bold>(c)</bold> anxious withdrawal for each group at the neuroimaging session, just prior to scanning. Bars indicate group means, whiskers indicate SEs, and dots indicate individual participants.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s002" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>Sample demographics, educational attainment.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s003" position="float" content-type="local-data">
                <label>S2 Table</label>
                <caption>
                  <title>Sample demographics, income.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s004" position="float" content-type="local-data">
                <label>S3 Table</label>
                <caption>
                  <title>Descriptive statistics for clusters and local extrema showing greater activity during the anticipation of Uncertain Threat compared to Uncertain Safety (FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s005" position="float" content-type="local-data">
                <label>S4 Table</label>
                <caption>
                  <title>Descriptive statistics for clusters and local extrema showing greater activity during the anticipation of Uncertain Safety compared to Uncertain Threat (FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s005.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s006" position="float" content-type="local-data">
                <label>S5 Table</label>
                <caption>
                  <title>Descriptive statistics for clusters and local extrema showing greater activity during the anticipation of Certain Threat compared to Certain Safety (FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s006.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s007" position="float" content-type="local-data">
                <label>S6 Table</label>
                <caption>
                  <title>Descriptive statistics for clusters and local extrema showing greater activity during the anticipation of Certain Safety compared to Certain Threat (FDR <italic toggle="yes">q</italic> &lt; .05, whole-brain corrected).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s007.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s008" position="float" content-type="local-data">
                <label>S7 Table</label>
                <caption>
                  <title>Descriptive statistics for clusters and local extrema showing greater activity during the anticipation of Uncertain <italic toggle="yes">and</italic> Certain Threat (minimum conjunction of FDR-thresholded maps).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s008.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s009" position="float" content-type="local-data">
                <label>S8 Table</label>
                <caption>
                  <title>One-sample Student’s <italic toggle="yes">t</italic>-tests for central extended amygdala regions of interest (spatially unsmoothed data).</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s009.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s010" position="float" content-type="local-data">
                <label>S9 Table</label>
                <caption>
                  <title>Spearman correlations among key outcome measures, all participants.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s010.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0288544.s011" position="float" content-type="local-data">
                <label>S10 Table</label>
                <caption>
                  <title>Spearman correlations among key outcome measures, nicotine-abstinent participants.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0288544.s011.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>Authors acknowledge assistance and critical feedback from L. Friedman, S. Grogans, M. Kuhn, R. Tillman, members of the Affective and Translational Neuroscience laboratory, and the staff of the Maryland Neuroimaging Center.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0288544.ref001">
                <label>1</label>
                <mixed-citation publication-type="book"><collab>IMHE</collab>. <part-title>Global Burden of Disease: Global, both sexes, all ages, disability adjusted life years (1990–2019)</part-title><publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>Institute for Health Metrics and Evaluation, University of Washington</publisher-name>; <year>2022</year> [cited 2022 September 1]. Available from: <ext-link xlink:href="http://ihmeuw.org/5v8k" ext-link-type="uri">http://ihmeuw.org/5v8k</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref002">
                <label>2</label>
                <mixed-citation publication-type="book"><collab>Office of the Surgeon General</collab>. <source>Smoking cessation: A report of the Surgeon General</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>U.S. Department of Health ans Human Services</publisher-name>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Cornelius</surname><given-names>ME</given-names></name>, <name><surname>Loretan</surname><given-names>CG</given-names></name>, <name><surname>Wang</surname><given-names>TW</given-names></name>, <name><surname>Jamal</surname><given-names>A</given-names></name>, <name><surname>Homa</surname><given-names>DM</given-names></name>. <article-title>Tobacco product use among adults—United States, 2020</article-title>. <source>Morbidity and Mortality Weekly Report</source>. <year>2020</year>;<volume>71</volume>:<fpage>397</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm7111a1</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref004">
                <label>4</label>
                <mixed-citation publication-type="book"><collab>CDC.</collab><part-title>Economic Trends in Tobacco</part-title><publisher-loc>Washinton, DC</publisher-loc>: <publisher-name>U.S. Department of Health &amp; Human Services</publisher-name>; <year>2022</year> [updated July 26, 2022; cited 2022 August 1]. Available from: <ext-link xlink:href="https://www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/" ext-link-type="uri">https://www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Le Foll</surname><given-names>B</given-names></name>, <name><surname>Piper</surname><given-names>ME</given-names></name>, <name><surname>Fowler</surname><given-names>CD</given-names></name>, <name><surname>Tonstad</surname><given-names>S</given-names></name>, <name><surname>Bierut</surname><given-names>L</given-names></name>, <name><surname>Lu</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Tobacco and nicotine use</article-title>. <source>Nature Reviews Disease Primers</source>. <year>2022</year>;<volume>8</volume>:<fpage>1</fpage>–<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41572-022-00346-w</pub-id>
<?supplied-pmid 35332148?><pub-id pub-id-type="pmid">35332148</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Babb</surname><given-names>S</given-names></name>, <name><surname>Malarcher</surname><given-names>A</given-names></name>, <name><surname>Schauer</surname><given-names>G</given-names></name>, <name><surname>Asman</surname><given-names>K</given-names></name>, <name><surname>Jamal</surname><given-names>A</given-names></name>. <article-title>Quitting smoking among adults—United States, 2000–2015</article-title>. <source>MMWR Morbidity and mortality weekly report</source>. <year>2017</year>;<volume>65</volume>:<fpage>1457</fpage>–<lpage>64</lpage>. Epub 2017/01/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.15585/mmwr.mm6552a1</pub-id> .<?supplied-pmid 28056007?><pub-id pub-id-type="pmid">28056007</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Keyser-Marcus</surname><given-names>LA</given-names></name>, <name><surname>Ramey</surname><given-names>T</given-names></name>, <name><surname>Bjork</surname><given-names>J</given-names></name>, <name><surname>Adams</surname><given-names>A</given-names></name>, <name><surname>Moeller</surname><given-names>FG</given-names></name>. <article-title>Development and feasibility study of an addiction-focused phenotyping assessment battery</article-title>. <source>The American journal on addictions</source>. <year>2021</year>;<volume>30</volume>:<fpage>398</fpage>–<lpage>405</lpage>. Epub 2021/04/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/ajad.13170</pub-id> ; PubMed Central PMCID: PMC8243823.<?supplied-pmid 33908104?><pub-id pub-id-type="pmid">33908104</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Kwako</surname><given-names>LE</given-names></name>, <name><surname>Schwandt</surname><given-names>ML</given-names></name>, <name><surname>Ramchandani</surname><given-names>VA</given-names></name>, <name><surname>Diazgranados</surname><given-names>N</given-names></name>, <name><surname>Koob</surname><given-names>GF</given-names></name>, <name><surname>Volkow</surname><given-names>ND</given-names></name>, <etal>et al</etal>. <article-title>Neurofunctional domains derived from deep behavioral phenotyping</article-title> in <source>Alcohol Use Disorder. Am J Psychiatry</source>. <year>2019</year>;<volume>176</volume>:<fpage>744</fpage>–<lpage>53</lpage>. Epub 2019/01/05. <comment>doi: </comment><pub-id pub-id-type="doi">10.1176/appi.ajp.2018.18030357</pub-id> ; PubMed Central PMCID: PMC6609498.<?supplied-pmid 30606047?><pub-id pub-id-type="pmid">30606047</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Volkow</surname><given-names>ND</given-names></name>, <name><surname>Koob</surname><given-names>GF</given-names></name>, <name><surname>McLellan</surname><given-names>AT</given-names></name>. <article-title>Neurobiologic advances from the brain disease model of addiction</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>:<fpage>363</fpage>–<lpage>71</lpage>. Epub 2016/01/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMra1511480</pub-id> .<?supplied-pmid 26816013?><pub-id pub-id-type="pmid">26816013</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Koob</surname><given-names>GF</given-names></name>, <name><surname>Volkow</surname><given-names>ND</given-names></name>. <article-title>Neurobiology of addiction: a neurocircuitry analysis</article-title>. <source>Lancet Psychiatry</source>. <year>2016</year>;<volume>3</volume>:<fpage>760</fpage>–<lpage>73</lpage>. Epub 2016/08/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2215-0366(16)00104-8</pub-id> .<?supplied-pmid 27475769?><pub-id pub-id-type="pmid">27475769</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Wise</surname><given-names>RA</given-names></name>, <name><surname>Koob</surname><given-names>GF</given-names></name>. <article-title>The development and maintenance of drug addiction</article-title>. <source>Neuropsychopharmacology</source>. <year>2014</year>;<volume>39</volume>:<fpage>254</fpage>–<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2013.261</pub-id> ; PubMed Central PMCID: PMC3870778.<?supplied-pmid 24121188?><pub-id pub-id-type="pmid">24121188</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Koob</surname><given-names>GF</given-names></name>. <article-title>The dark side of emotion: The addiction perspective</article-title>. <source>Eur J Pharmacol</source>. <year>2015</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ejphar.2014.11.044</pub-id> .<?supplied-pmid 25583178?><pub-id pub-id-type="pmid">25583178</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Koob</surname><given-names>GF</given-names></name>. <article-title>A role for brain stress systems in addiction</article-title>. <source>Neuron</source>. <year>2008</year>;<volume>59</volume>:<fpage>11</fpage>–<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuron.2008.06.012</pub-id> ; PubMed Central PMCID: PMC2748830.<?supplied-pmid 18614026?><pub-id pub-id-type="pmid">18614026</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>TB</given-names></name>, <name><surname>Piper</surname><given-names>ME</given-names></name>, <name><surname>McCarthy</surname><given-names>DE</given-names></name>, <name><surname>Majeskie</surname><given-names>MR</given-names></name>, <name><surname>Fiore</surname><given-names>MC</given-names></name>. <article-title>Addiction motivation reformulated: an affective processing model of negative reinforcement.</article-title><source>Psychol Rev</source>. <year>2004</year>;<volume>111</volume>:<fpage>33</fpage>–<lpage>51</lpage>. Epub 2004/02/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/0033-295X.111.1.33</pub-id> [pii]. .<?supplied-pmid 14756584?><pub-id pub-id-type="pmid">14756584</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>TB</given-names></name>, <name><surname>Japuntich</surname><given-names>SJ</given-names></name>, <name><surname>Hogle</surname><given-names>JM</given-names></name>, <name><surname>McCarthy</surname><given-names>DE</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Pharmacologic and behavioral withdrawal from addictive drugs</article-title>. <source>Curr Dir Psychol Sci</source>. <year>2006</year>;<volume>15</volume>:<fpage>232</fpage>–<lpage>36</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Fronk</surname><given-names>GE</given-names></name>, <name><surname>Sant’Ana</surname><given-names>SJ</given-names></name>, <name><surname>Kaye</surname><given-names>JT</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Stress allostasis in substance use disorders: Promise, progress, and emerging priorities in clinical research.</article-title><source>Annual Review of Clinical Psychology</source>. <year>2020</year>;<volume>16</volume>:<fpage>401</fpage>–<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-102419-125016</pub-id>
<?supplied-pmid 32040338?><pub-id pub-id-type="pmid">32040338</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Shiffman</surname><given-names>S.</given-names></name><article-title>Cognitive antecedents and sequelae of smoking relapse crises</article-title>. <source>Journal of Applied Social Psychology</source>. <year>1984</year>;<volume>14</volume>:<fpage>296</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1111/j.1559-1816.1984.tb02238.x</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref018">
                <label>18</label>
                <mixed-citation publication-type="book"><collab>APA</collab>. <part-title>Diagnostic and statistical manual of mental disorders, text revision (DSM-5-TR).</part-title><edition designator="5">5 ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>; <year>2022</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Conti</surname><given-names>AA</given-names></name>, <name><surname>Tolomeo</surname><given-names>S</given-names></name>, <name><surname>Steele</surname><given-names>JD</given-names></name>, <name><surname>Baldacchino</surname><given-names>AM</given-names></name>. <article-title>Severity of negative mood and anxiety symptoms occurring during acute abstinence from tobacco: A systematic review and meta-analysis. Neuroscience &amp;</article-title><source>Biobehavioral Reviews</source>. <year>2020</year>;<volume>115</volume>:<fpage>48</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.04.018</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Hughes</surname><given-names>JR</given-names></name>. <article-title>Effects of abstinence from tobacco: valid symptoms and time course.</article-title><source>Nicotine &amp; tobacco research: official journal of the Society for Research on Nicotine and Tobacco</source>. <year>2007</year>;<volume>9</volume>:<fpage>315</fpage>–<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/14622200701188919</pub-id> .<?supplied-pmid 17365764?><pub-id pub-id-type="pmid">17365764</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>DE</given-names></name>, <name><surname>Piasecki</surname><given-names>TM</given-names></name>, <name><surname>Fiore</surname><given-names>MC</given-names></name>, <name><surname>Baker</surname><given-names>TB</given-names></name>. <article-title>Life before and after quitting smoking: An electronic diary study</article-title>. <source>Journal of Abnormal Psychology</source>. <year>2006</year>;<volume>115</volume>:<fpage>454</fpage>–<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/0021-843X.115.3.454</pub-id>
<?supplied-pmid 16866586?><pub-id pub-id-type="pmid">16866586</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Shiffman</surname><given-names>S</given-names></name>, <name><surname>Paty</surname><given-names>JA</given-names></name>, <name><surname>Gnys</surname><given-names>M</given-names></name>, <name><surname>Kassel</surname><given-names>JA</given-names></name>, <name><surname>Hickcox</surname><given-names>M</given-names></name>. <article-title>First lapses to smoking: within-subjects analysis of real-time reports.</article-title><source>J Consult Clin Psychol</source>. <year>1996</year>;<volume>64</volume>:<fpage>366</fpage>–<lpage>79</lpage>. Epub 1996/04/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037//0022-006x.64.2.366</pub-id> .<?supplied-pmid 8871421?><pub-id pub-id-type="pmid">8871421</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>SG</given-names></name>, <name><surname>Shiffman</surname><given-names>S</given-names></name>, <name><surname>Blizzard</surname><given-names>L</given-names></name>. <article-title>Triggers of Smoking Lapses Over the Course of a Quit Attempt</article-title>. <source>Journal of Smoking Cessation</source>. <year>2017</year>;<volume>12</volume>:<fpage>205</fpage>–<lpage>12</lpage>. Epub 2016/08/31. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/jsc.2016.21</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Shiffman</surname><given-names>S.</given-names></name><article-title>Dynamic influences on smoking relapse process</article-title>. <source>J Pers</source>. <year>2005</year>;<volume>73</volume>:<fpage>1715</fpage>–<lpage>48</lpage>. Epub 2005/11/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.0022-3506.2005.00364.x</pub-id> .<?supplied-pmid 16274451?><pub-id pub-id-type="pmid">16274451</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Minami</surname><given-names>H</given-names></name>, <name><surname>Yeh</surname><given-names>VM</given-names></name>, <name><surname>Bold</surname><given-names>KW</given-names></name>, <name><surname>Chapman</surname><given-names>GB</given-names></name>, <name><surname>McCarthy</surname><given-names>DE</given-names></name>. <article-title>Relations among affect, abstinence motivation and confidence, and daily smoking lapse risk.</article-title><source>Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors.</source><year>2014</year>;<volume>28</volume>:<fpage>376</fpage>–<lpage>88</lpage>. Epub 2014/06/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/a0034445</pub-id> ; PubMed Central PMCID: PMC4997809.<?supplied-pmid 24955665?><pub-id pub-id-type="pmid">24955665</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Bold</surname><given-names>KW</given-names></name>, <name><surname>McCarthy</surname><given-names>DE</given-names></name>, <name><surname>Minami</surname><given-names>H</given-names></name>, <name><surname>Yeh</surname><given-names>VM</given-names></name>, <name><surname>Chapman</surname><given-names>GB</given-names></name>, <name><surname>Waters</surname><given-names>AJ</given-names></name>. <article-title>Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit</article-title>. <source>Drug Alcohol Depend</source>. <year>2016</year>;<volume>158</volume>:<fpage>30</fpage>–<lpage>7</lpage>. Epub 2015/11/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.10.024</pub-id> ; PubMed Central PMCID: PMC4698113.<?supplied-pmid 26585613?><pub-id pub-id-type="pmid">26585613</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Cofta-Woerpel</surname><given-names>L</given-names></name>, <name><surname>McClure</surname><given-names>JB</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Urbauer</surname><given-names>D</given-names></name>, <name><surname>Cinciripini</surname><given-names>PM</given-names></name>, <name><surname>Wetter</surname><given-names>DW</given-names></name>. <article-title>Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week.</article-title><source>J Abnorm Psychol</source>. <year>2011</year>;<volume>120</volume>(<issue>3</issue>):<fpage>596</fpage>–<lpage>606</lpage>. Epub 2011/05/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/a0023755</pub-id> ; PubMed Central PMCID: PMC3153568.<?supplied-pmid 21574667?><pub-id pub-id-type="pmid">21574667</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Heckman</surname><given-names>BW</given-names></name>, <name><surname>Carpenter</surname><given-names>MJ</given-names></name>, <name><surname>Correa</surname><given-names>JB</given-names></name>, <name><surname>Wray</surname><given-names>JM</given-names></name>, <name><surname>Saladin</surname><given-names>ME</given-names></name>, <name><surname>Froeliger</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis.</article-title><source>Addiction (Abingdon, England).</source><year>2015</year>;<volume>110</volume>:<fpage>751</fpage>–<lpage>60</lpage>. Epub 2015/02/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/add.12866</pub-id> ; PubMed Central PMCID: PMC4398635.<?supplied-pmid 25641624?><pub-id pub-id-type="pmid">25641624</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Heckman</surname><given-names>BW</given-names></name>, <name><surname>Kovacs</surname><given-names>MA</given-names></name>, <name><surname>Marquinez</surname><given-names>NS</given-names></name>, <name><surname>Meltzer</surname><given-names>LR</given-names></name>, <name><surname>Tsambarlis</surname><given-names>ME</given-names></name>, <name><surname>Drobes</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. <article-title>Influence of affective manipulations on cigarette craving: a meta-analysis.</article-title><source>Addiction (Abingdon, England).</source><year>2013</year>;<volume>108</volume>(<issue>12</issue>):<fpage>2068</fpage>–<lpage>78</lpage>. Epub 2013/06/26. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/add.12284</pub-id> ; PubMed Central PMCID: PMC3830730.<?supplied-pmid 23795674?><pub-id pub-id-type="pmid">23795674</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>SL</given-names></name>, <name><surname>Martin</surname><given-names>LE</given-names></name>, <name><surname>Catley</surname><given-names>D</given-names></name>. <article-title>Trial-by-trial fluctuations in brain responses to stress predict subsequent smoking decisions that occur several seconds later</article-title>. <source>Biol Psychiatry Cogn Neurosci Neuroimaging</source>. <year>2020</year>;<volume>5</volume>:<fpage>1019</fpage>–<lpage>27</lpage>. Epub 2020/08/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bpsc.2020.06.012</pub-id> ; PubMed Central PMCID: PMC7655713.<?supplied-pmid 32828721?><pub-id pub-id-type="pmid">32828721</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Hogle</surname><given-names>JM</given-names></name>, <name><surname>Kaye</surname><given-names>JT</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction</article-title>. <source>Biol Psychiatry</source>. <year>2010</year>;<volume>68</volume>:<fpage>719</fpage>–<lpage>25</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biopsych.2010.06.003</pub-id> ; PubMed Central PMCID: PMC2949532.<?supplied-pmid 20673878?><pub-id pub-id-type="pmid">20673878</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Bradford</surname><given-names>DE</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>, <name><surname>Piper</surname><given-names>ME</given-names></name>. <article-title>Anticipation of smoking sufficiently dampens stress reactivity in nicotine-deprived smokers.</article-title><source>J Abnorm Psychol</source>. <year>2015</year>;<volume>124</volume>:<fpage>128</fpage>–<lpage>36</lpage>. Epub 2015/02/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/abn0000007</pub-id> ; PubMed Central PMCID: PMC4332561.<?supplied-pmid 25688439?><pub-id pub-id-type="pmid">25688439</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Oler</surname><given-names>JA</given-names></name>, <name><surname>Tromp</surname><given-names>DP</given-names></name>, <name><surname>Fudge</surname><given-names>JL</given-names></name>, <name><surname>Kalin</surname><given-names>NH</given-names></name>. <article-title>Extending the amygdala in theories of threat processing</article-title>. <source>Trends Neurosci</source>. <year>2015</year>;<volume>38</volume>:<fpage>319</fpage>–<lpage>29</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tins.2015.03.002</pub-id> .<?supplied-pmid 25851307?><pub-id pub-id-type="pmid">25851307</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Shackman</surname><given-names>AJ</given-names></name>. <article-title>The central extended amygdala in fear and anxiety: Closing the gap between mechanistic and neuroimaging research</article-title>. <source>Neuroscience Letters</source>. <year>2019</year>;<volume>693</volume>:<fpage>58</fpage>–<lpage>67</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neulet.2017.11.056</pub-id>
<?supplied-pmid 29195911?><pub-id pub-id-type="pmid">29195911</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>George</surname><given-names>O</given-names></name>, <name><surname>Ghozland</surname><given-names>S</given-names></name>, <name><surname>Azar</surname><given-names>MR</given-names></name>, <name><surname>Cottone</surname><given-names>P</given-names></name>, <name><surname>Zorrilla</surname><given-names>EP</given-names></name>, <name><surname>Parsons</surname><given-names>LH</given-names></name>, <etal>et al</etal>. <article-title>CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>;<volume>104</volume>:<fpage>17198</fpage>–<lpage>203</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.0707585104</pub-id> ; PubMed Central PMCID: PMC2040467.<?supplied-pmid 17921249?><pub-id pub-id-type="pmid">17921249</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Arakaki</surname><given-names>S</given-names></name>, <name><surname>Minami</surname><given-names>M</given-names></name>. <article-title>Role of noradrenergic transmission within the ventral bed nucleus of the stria terminalis in nicotine withdrawal-induced aversive behavior</article-title>. <source>Neuropsychopharmacology reports</source>. <year>2022</year>;<volume>42</volume>:<fpage>233</fpage>–<lpage>7</lpage>. Epub 2022/04/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/npr2.12252</pub-id> ; PubMed Central PMCID: PMC9216371.<?supplied-pmid 35437943?><pub-id pub-id-type="pmid">35437943</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Yamada</surname><given-names>H</given-names></name>, <name><surname>Bruijnzeel</surname><given-names>AW</given-names></name>. <article-title>Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats</article-title>. <source>Neuropharmacology</source>. <year>2011</year>;<volume>60</volume>:<fpage>303</fpage>–<lpage>11</lpage>. Epub 2010/09/22. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.09.013</pub-id> ; PubMed Central PMCID: PMC3014445.<?supplied-pmid 20854830?><pub-id pub-id-type="pmid">20854830</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>A</given-names></name>, <name><surname>Treweek</surname><given-names>J</given-names></name>, <name><surname>Edwards</surname><given-names>S</given-names></name>, <name><surname>Leão</surname><given-names>RM</given-names></name>, <name><surname>Schulteis</surname><given-names>G</given-names></name>, <name><surname>Koob</surname><given-names>GF</given-names></name>, <etal>et al</etal>. <article-title>Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats</article-title>. <source>Addict Biol</source>. <year>2015</year>;<volume>20</volume>:<fpage>56</fpage>–<lpage>68</lpage>. Epub 2013/07/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/adb.12077</pub-id> ; PubMed Central PMCID: PMC3859819.<?supplied-pmid 23869743?><pub-id pub-id-type="pmid">23869743</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Van Essen</surname><given-names>DC</given-names></name>, <name><surname>Donahue</surname><given-names>CJ</given-names></name>, <name><surname>Coalson</surname><given-names>TS</given-names></name>, <name><surname>Kennedy</surname><given-names>H</given-names></name>, <name><surname>Hayashi</surname><given-names>T</given-names></name>, <name><surname>Glasser</surname><given-names>MF</given-names></name>. <article-title>Cerebral cortical folding, parcellation, and connectivity in humans, nonhuman primates, and mice</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2019</year>;<volume>116</volume>:<fpage>26173</fpage>–<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1902299116</pub-id>
<?supplied-pmid 31871175?><pub-id pub-id-type="pmid">31871175</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Benton</surname><given-names>MJ</given-names></name>, <name><surname>Donoghue</surname><given-names>PC</given-names></name>. <article-title>Paleontological evidence to date the tree of life</article-title>. <source>Molecular biology and evolution</source>. <year>2007</year>;<volume>24</volume>:<fpage>26</fpage>–<lpage>53</lpage>. Epub 2006/10/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/molbev/msl150</pub-id> .<?supplied-pmid 17047029?><pub-id pub-id-type="pmid">17047029</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Spierling</surname><given-names>SR</given-names></name>, <name><surname>Zorrilla</surname><given-names>EP</given-names></name>. <article-title>Don’t stress about CRF: assessing the translational failures of CRF(1)antagonists.</article-title><source>Psychopharmacology</source> (Berl). <year>2017</year>;<volume>234</volume>:<fpage>1467</fpage>–<lpage>81</lpage>. Epub 2017/03/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00213-017-4556-2</pub-id> ; PubMed Central PMCID: PMC5420464.<?supplied-pmid 28265716?><pub-id pub-id-type="pmid">28265716</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Hur</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>JF</given-names></name>, <name><surname>DeYoung</surname><given-names>KA</given-names></name>, <name><surname>Anderson</surname><given-names>AS</given-names></name>, <name><surname>Kuang</surname><given-names>J</given-names></name>, <name><surname>Kim</surname><given-names>HC</given-names></name>, <etal>et al</etal>. <article-title>Anxiety and the neurobiology of temporally uncertain threat anticipation</article-title>. <source>Journal of Neuroscience</source>. <year>2020</year>;<volume>40</volume>:<fpage>7949</fpage>–<lpage>64</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0704-20.2020</pub-id>
<?supplied-pmid 32958570?><pub-id pub-id-type="pmid">32958570</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Hur</surname><given-names>J</given-names></name>, <name><surname>Kuhn</surname><given-names>M</given-names></name>, <name><surname>Grogans</surname><given-names>SE</given-names></name>, <name><surname>Anderson</surname><given-names>AS</given-names></name>, <name><surname>Islam</surname><given-names>S</given-names></name>, <name><surname>Kim</surname><given-names>HC</given-names></name>, <etal>et al</etal>. <article-title>Anxiety-related frontocortical activity is associated with dampened stressor reactivity in the real world</article-title>. <source>Psychological Science</source>. <year>2022</year>;<volume>33</volume>:<fpage>906</fpage>–<lpage>24</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/09567976211056635</pub-id>
<?supplied-pmid 35657777?><pub-id pub-id-type="pmid">35657777</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Schwandt</surname><given-names>ML</given-names></name>, <name><surname>Cortes</surname><given-names>CR</given-names></name>, <name><surname>Kwako</surname><given-names>LE</given-names></name>, <name><surname>George</surname><given-names>DT</given-names></name>, <name><surname>Momenan</surname><given-names>R</given-names></name>, <name><surname>Sinha</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>The CRF1 antagonist verucerfont in anxious alcohol-dependent women: Translation of neuroendocrine, but not of anti-craving effects</article-title>. <source>Neuropsychopharmacology</source>. <year>2016</year>;<volume>41</volume>:<fpage>2818</fpage>–<lpage>29</lpage>. Epub 2016/04/26. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2016.61</pub-id> ; PubMed Central PMCID: PMC5061889.<?supplied-pmid 27109623?><pub-id pub-id-type="pmid">27109623</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Kwako</surname><given-names>LE</given-names></name>, <name><surname>Spagnolo</surname><given-names>PA</given-names></name>, <name><surname>Schwandt</surname><given-names>ML</given-names></name>, <name><surname>Thorsell</surname><given-names>A</given-names></name>, <name><surname>George</surname><given-names>DT</given-names></name>, <name><surname>Momenan</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study</article-title>. <source>Neuropsychopharmacology</source>. <year>2015</year>;<volume>40</volume>:<fpage>1053</fpage>–<lpage>63</lpage>. Epub 2014/11/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2014.306</pub-id> ; PubMed Central PMCID: PMC4367465.<?supplied-pmid 25409596?><pub-id pub-id-type="pmid">25409596</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Hur</surname><given-names>J</given-names></name>, <name><surname>Kaplan</surname><given-names>CM</given-names></name>, <name><surname>Smith</surname><given-names>JF</given-names></name>, <name><surname>Bradford</surname><given-names>DE</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Acute alcohol administration dampens central extended amygdala reactivity</article-title>. <source>Scientific Reports</source>. <year>2018</year>;<volume>8</volume>:<fpage>16702</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-34987-3</pub-id><?supplied-pmid 30420682?><pub-id pub-id-type="pmid">30420682</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Hur</surname><given-names>J</given-names></name>, <name><surname>Stockbridge</surname><given-names>MD</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Shackman</surname><given-names>AJ</given-names></name>. <article-title>Dispositional negativity, cognition, and anxiety disorders: An integrative translational neuroscience framework</article-title>. <source>Progress in Brain Research</source>. <year>2019</year>;<volume>247</volume>:<fpage>375</fpage>–<lpage>436</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/bs.pbr.2019.03.012</pub-id>
<?supplied-pmid 31196442?><pub-id pub-id-type="pmid">31196442</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Poldrack</surname><given-names>RA</given-names></name>, <name><surname>Baker</surname><given-names>CI</given-names></name>, <name><surname>Durnez</surname><given-names>J</given-names></name>, <name><surname>Gorgolewski</surname><given-names>KJ</given-names></name>, <name><surname>Matthews</surname><given-names>PM</given-names></name>, <name><surname>Munafò</surname><given-names>MR</given-names></name>, <etal>et al</etal>. <article-title>Scanning the horizon: towards transparent and reproducible neuroimaging research</article-title>. <source>Nature Reviews Neuroscience</source>. <year>2017</year>;<volume>18</volume>:<fpage>115</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrn.2016.167</pub-id>
<?supplied-pmid 28053326?><pub-id pub-id-type="pmid">28053326</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Borsook</surname><given-names>D</given-names></name>, <name><surname>Becerra</surname><given-names>L</given-names></name>, <name><surname>Hargreaves</surname><given-names>R</given-names></name>. <article-title>A role for fMRI in optimizing CNS drug development</article-title>. <source>Nat Rev Drug Discov</source>. <year>2006</year>;<volume>5</volume>:<fpage>411</fpage>–<lpage>24</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrd2027</pub-id> .<?supplied-pmid 16604100?><pub-id pub-id-type="pmid">16604100</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Lerman</surname><given-names>C</given-names></name>, <name><surname>LeSage</surname><given-names>MG</given-names></name>, <name><surname>Perkins</surname><given-names>KA</given-names></name>, <name><surname>O’Malley</surname><given-names>SS</given-names></name>, <name><surname>Siegel</surname><given-names>SJ</given-names></name>, <name><surname>Benowitz</surname><given-names>NL</given-names></name>, <etal>et al</etal>. <article-title>Translational research in medication development for nicotine dependence</article-title>. <source>Nat Rev Drug Discov</source>. <year>2007</year>;<volume>6</volume>(<issue>9</issue>):<fpage>746</fpage>–<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrd2361</pub-id> .<?supplied-pmid 17690709?><pub-id pub-id-type="pmid">17690709</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>M</given-names></name>, <name><surname>Walker</surname><given-names>DL</given-names></name>, <name><surname>Miles</surname><given-names>L</given-names></name>, <name><surname>Grillon</surname><given-names>C</given-names></name>. <article-title>Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety</article-title>. <source>Neuropsychopharmacology</source>. <year>2010</year>;<volume>35</volume>:<fpage>105</fpage>–<lpage>35</lpage>. Epub 2009/08/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2009.109</pub-id> [pii] .<?supplied-pmid 19693004?><pub-id pub-id-type="pmid">19693004</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>LeDoux</surname><given-names>JE</given-names></name>, <name><surname>Pine</surname><given-names>DS</given-names></name>. <article-title>Using neuroscience to help understand fear and anxiety: A two-system framework</article-title>. <source>Am J Psychiatry</source>. <year>2016</year>;<volume>173</volume>:<fpage>1083</fpage>–<lpage>93</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1176/appi.ajp.2016.16030353</pub-id> .<?supplied-pmid 27609244?><pub-id pub-id-type="pmid">27609244</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref053">
                <label>53</label>
                <mixed-citation publication-type="book"><name><surname>Freud</surname><given-names>S.</given-names></name><source>A general introduction to psychoanalysis</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Boni and Liveright</publisher-name>; <year>1920</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>. <article-title>Contributions of the central extended amygdala to fear and anxiety</article-title>. <source>Journal of Neuroscience</source>. <year>2016</year>;<volume>36</volume>:<fpage>8050</fpage>–<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0982-16.2016</pub-id> .<?supplied-pmid 27488625?><pub-id pub-id-type="pmid">27488625</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Mobbs</surname><given-names>D</given-names></name>, <name><surname>Adolphs</surname><given-names>R</given-names></name>, <name><surname>Fanselow</surname><given-names>MS</given-names></name>, <name><surname>Barrett</surname><given-names>LF</given-names></name>, <name><surname>LeDoux</surname><given-names>JE</given-names></name>, <name><surname>Ressler</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Viewpoints: Approaches to defining and investigating fear</article-title>. <source>Nature Neuroscience</source>. <year>2019</year>;<volume>22</volume>:<fpage>1205</fpage>–<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41593-019-0456-6</pub-id>
<?supplied-pmid 31332374?><pub-id pub-id-type="pmid">31332374</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref056">
                <label>56</label>
                <mixed-citation publication-type="other">NIMH. Negative valence systems: Workshop proceedings (March 13, 2011 –March 15, 2011; Rockville, Maryland) 2011 [cited 2020 July 1]. Available from: <ext-link xlink:href="https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/negative-valence-systems-workshop-proceedings.shtml" ext-link-type="uri">https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/negative-valence-systems-workshop-proceedings.shtml</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Grogans</surname><given-names>SE</given-names></name>, <name><surname>Bliss-Moreau</surname><given-names>E</given-names></name>, <name><surname>Buss</surname><given-names>KA</given-names></name>, <name><surname>Clark</surname><given-names>LA</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Keltner</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>The nature and neurobiology of fear and anxiety: State of the science and opportunities for accelerating discovery.</article-title><source>Neuroscience &amp; Biobehavioral Reviews.</source><italic toggle="yes">accepted in principle</italic>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neubiorev.2023.105237</pub-id><?supplied-pmid 37209932?><pub-id pub-id-type="pmid">37209932</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Piper</surname><given-names>ME</given-names></name>, <name><surname>Smith</surname><given-names>SS</given-names></name>, <name><surname>Schlam</surname><given-names>TR</given-names></name>, <name><surname>Fiore</surname><given-names>MC</given-names></name>, <name><surname>Jorenby</surname><given-names>DE</given-names></name>, <name><surname>Fraser</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.</article-title><source>Arch Gen Psychiatry</source>. <year>2009</year>;<volume>66</volume>:<fpage>1253</fpage>–<lpage>62</lpage>. Epub 2009/11/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.142</pub-id> ; PubMed Central PMCID: PMC2933113.<?supplied-pmid 19884613?><pub-id pub-id-type="pmid">19884613</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Perkins</surname><given-names>KA</given-names></name>, <name><surname>Karelitz</surname><given-names>JL</given-names></name>, <name><surname>Jao</surname><given-names>NC</given-names></name>. <article-title>Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence</article-title>. <source>Nicotine &amp; tobacco research: official journal of the Society for Research on Nicotine and Tobacco</source>. <year>2013</year>;<volume>15</volume>(<issue>5</issue>):<fpage>978</fpage>–<lpage>82</lpage>. Epub 2012/09/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ntr/nts205</pub-id> ; PubMed Central PMCID: PMC3733388.<?supplied-pmid 22990219?><pub-id pub-id-type="pmid">22990219</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref060">
                <label>60</label>
                <mixed-citation publication-type="book"><collab>Tobacco Use and Dependence Guideline Panel.</collab><part-title>Treating tobacco use and dependence: 2008 Update.</part-title><publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services</publisher-name>; <year>2008</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Bradford</surname><given-names>DE</given-names></name>, <name><surname>DeFalco</surname><given-names>A</given-names></name>, <name><surname>Perkins</surname><given-names>ER</given-names></name>, <name><surname>Carvajal</surname><given-names>I</given-names></name>, <name><surname>Kwasa</surname><given-names>J</given-names></name>, <name><surname>Goodman</surname><given-names>FR</given-names></name>, <etal>et al</etal>. <article-title>Whose signals are we amplifying? Towards a more equitable clinical psychophysiology</article-title>. <source>Clinical Psychological Science. <italic toggle="yes">in press</italic></source>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Webb</surname><given-names>EK</given-names></name>, <name><surname>Etter</surname><given-names>JA</given-names></name>, <name><surname>Kwasa</surname><given-names>JA</given-names></name>. <article-title>Addressing racial and phenotypic bias in human neuroscience methods</article-title>. <source>Nature Neuroscience</source>. <year>2022</year>;<volume>25</volume>:<fpage>410</fpage>–<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41593-022-01046-0</pub-id>
<?supplied-pmid 35383334?><pub-id pub-id-type="pmid">35383334</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Erdfelder</surname><given-names>E</given-names></name>, <name><surname>Faul</surname><given-names>F</given-names></name>, <name><surname>Buchner</surname><given-names>A</given-names></name>. <article-title>GPOWER: A general power analysis program</article-title>. <source>Behavior Research Methods, Instruments &amp; Computers</source>. <year>1996</year>;<volume>28</volume>:<fpage>1</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3758/BF03203630</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>Grillon</surname><given-names>C</given-names></name>, <name><surname>Avenevoli</surname><given-names>S</given-names></name>, <name><surname>Daurignac</surname><given-names>E</given-names></name>, <name><surname>Merikangas</surname><given-names>KR</given-names></name>. <article-title>Fear-potentiated startle to threat, and prepulse inhibition among young adult nonsmokers, abstinent smokers, and nonabstinent smokers</article-title>. <source>Biol Psychiatry</source>. <year>2007</year>. Epub 2007/06/05. S0006-3223(07)00011-X [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.12.027</pub-id> .<?supplied-pmid 17543892?><pub-id pub-id-type="pmid">17543892</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>RW</given-names></name>. <article-title>AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages</article-title>. <source>Computers and Biomedical Research</source>. <year>1996</year>;<volume>29</volume>:<fpage>162</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1006/cbmr.1996.0014</pub-id>
<?supplied-pmid 8812068?><pub-id pub-id-type="pmid">8812068</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref066">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Heatherton</surname><given-names>TF</given-names></name>, <name><surname>Kozlowski</surname><given-names>LT</given-names></name>, <name><surname>Frecker</surname><given-names>RC</given-names></name>, <name><surname>Fagerström</surname><given-names>KO</given-names></name>. <article-title>The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.</article-title><source>British journal of addiction</source>. <year>1991</year>;<volume>86</volume>(<issue>9</issue>):<fpage>1119</fpage>–<lpage>27</lpage>. Epub 1991/09/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1360-0443.1991.tb01879.x</pub-id> .<?supplied-pmid 1932883?><pub-id pub-id-type="pmid">1932883</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref067">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>Pomerleau</surname><given-names>CS</given-names></name>, <name><surname>Majchrzak</surname><given-names>MJ</given-names></name>, <name><surname>Pomerleau</surname><given-names>OF</given-names></name>. <article-title>Nicotine dependence and the Fagerström Tolerance Questionnaire: a brief review</article-title>. <source>Journal of substance abuse</source>. <year>1989</year>;<volume>1</volume>(<issue>4</issue>):<fpage>471</fpage>–<lpage>7</lpage>. Epub 1989/01/01. .<?supplied-pmid 2485293?><pub-id pub-id-type="pmid">2485293</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Fagerström</surname><given-names>K.</given-names></name><article-title>Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence.</article-title><source>Nicotine &amp; Tobacco Research</source>. <year>2012</year>;<volume>14</volume>:<fpage>75</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ntr/ntr137</pub-id>
<?supplied-pmid 22025545?><pub-id pub-id-type="pmid">22025545</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Piper</surname><given-names>ME</given-names></name>, <name><surname>Piasecki</surname><given-names>TM</given-names></name>, <name><surname>Federman</surname><given-names>EB</given-names></name>, <name><surname>Bolt</surname><given-names>DM</given-names></name>, <name><surname>Smith</surname><given-names>SS</given-names></name>, <name><surname>Fiore</surname><given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>A multiple motives approach to tobacco dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). Journal of Consulting &amp;</article-title><source>Clinical Psychology</source>. <year>2004</year>;<volume>72</volume>:<fpage>139</fpage>–<lpage>54</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Welsch</surname><given-names>SK</given-names></name>, <name><surname>Smith</surname><given-names>SS</given-names></name>, <name><surname>Wetter</surname><given-names>DW</given-names></name>, <name><surname>Jorenby</surname><given-names>DE</given-names></name>, <name><surname>Fiore</surname><given-names>MC</given-names></name>, <name><surname>Baker</surname><given-names>TB</given-names></name>. <article-title>Development and validation of the Wisconsin Smoking Withdrawal Scale</article-title>. <source>Exp Clin Psychopharmacol</source>. <year>1999</year>;<volume>7</volume>(<issue>4</issue>):<fpage>354</fpage>–<lpage>61</lpage>. Epub 1999/12/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037//1064-1297.7.4.354</pub-id> .<?supplied-pmid 10609970?><pub-id pub-id-type="pmid">10609970</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Daldrup</surname><given-names>T</given-names></name>, <name><surname>Remmes</surname><given-names>J</given-names></name>, <name><surname>Lesting</surname><given-names>J</given-names></name>, <name><surname>Gaburro</surname><given-names>S</given-names></name>, <name><surname>Fendt</surname><given-names>M</given-names></name>, <name><surname>Meuth</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Expression of freezing and fear-potentiated startle during sustained fear in mice</article-title>. <source>Genes Brain Behav</source>. <year>2015</year>;<volume>14</volume>:<fpage>281</fpage>–<lpage>91</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/gbb.12211</pub-id> .<?supplied-pmid 25761115?><pub-id pub-id-type="pmid">25761115</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Lange</surname><given-names>MD</given-names></name>, <name><surname>Daldrup</surname><given-names>T</given-names></name>, <name><surname>Remmers</surname><given-names>F</given-names></name>, <name><surname>Szkudlarek</surname><given-names>HJ</given-names></name>, <name><surname>Lesting</surname><given-names>J</given-names></name>, <name><surname>Guggenhuber</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat</article-title>. <source>Mol Psychiatry</source>. <year>2017</year>;<volume>22</volume>:<fpage>1422</fpage>–<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/mp.2016.156</pub-id> .<?supplied-pmid 27698427?><pub-id pub-id-type="pmid">27698427</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Miles</surname><given-names>L</given-names></name>, <name><surname>Davis</surname><given-names>M</given-names></name>, <name><surname>Walker</surname><given-names>D</given-names></name>. <article-title>Phasic and sustained fear are pharmacologically dissociable in rats</article-title>. <source>Neuropsychopharmacology</source>. <year>2011</year>;<volume>36</volume>:<fpage>1563</fpage>–<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2011.29</pub-id> ; PubMed Central PMCID: PMC3138660.<?supplied-pmid 21471958?><pub-id pub-id-type="pmid">21471958</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref074">
                <label>74</label>
                <mixed-citation publication-type="journal"><name><surname>Hefner</surname><given-names>KR</given-names></name>, <name><surname>Moberg</surname><given-names>CA</given-names></name>, <name><surname>Hachiya</surname><given-names>LY</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Alcohol stress response dampening during imminent versus distal, uncertain threat.</article-title><source>J Abnorm Psychol.</source><year>2013</year>;<volume>122</volume>:<fpage>756</fpage>–<lpage>69</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/a0033407</pub-id> .<?supplied-pmid 24016014?><pub-id pub-id-type="pmid">24016014</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref075">
                <label>75</label>
                <mixed-citation publication-type="book"><name><surname>Henson</surname><given-names>R.</given-names></name><part-title>Efficient experimental design for fMRI</part-title>. In: <name><surname>Friston</surname><given-names>K</given-names></name>, <name><surname>Ashburner</surname><given-names>J</given-names></name>, <name><surname>Kiebel</surname><given-names>S</given-names></name>, <name><surname>Nichols</surname><given-names>T</given-names></name>, <name><surname>Penny</surname><given-names>W</given-names></name>, editors. <source>Statistical parametric mapping: The analysis of functional brain images.</source><publisher-loc>New York, NY</publisher-loc>: <publisher-name>Academic Press</publisher-name>; <year>2007</year>. p. <fpage>193</fpage>–<lpage>210</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Bach</surname><given-names>DR</given-names></name>, <name><surname>Friston</surname><given-names>KJ</given-names></name>. <article-title>Model-based analysis of skin conductance responses: Towards causal models in psychophysiology.</article-title><source>Psychophysiology.</source><year>2013</year>;<volume>50</volume>:<fpage>15</fpage>–<lpage>22</lpage>. Epub 2012/10/26. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1469-8986.2012.01483.x</pub-id> .<?supplied-pmid 23094650?><pub-id pub-id-type="pmid">23094650</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Bach</surname><given-names>DR</given-names></name>, <name><surname>Castegnetti</surname><given-names>G</given-names></name>, <name><surname>Korn</surname><given-names>CW</given-names></name>, <name><surname>Gerster</surname><given-names>S</given-names></name>, <name><surname>Melinscak</surname><given-names>F</given-names></name>, <name><surname>Moser</surname><given-names>T</given-names></name>. <article-title>Psychophysiological modeling: Current state and future directions.</article-title><source>Psychophysiology</source>. <year>2018</year>;<volume>55</volume>:<fpage>e13214</fpage>. Epub 2018/09/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/psyp.13209</pub-id> .<?supplied-pmid 30175471?><pub-id pub-id-type="pmid">30175471</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref078">
                <label>78</label>
                <mixed-citation publication-type="journal"><name><surname>Bach</surname><given-names>DR</given-names></name>, <name><surname>Flandin</surname><given-names>G</given-names></name>, <name><surname>Friston</surname><given-names>KJ</given-names></name>, <name><surname>Dolan</surname><given-names>RJ</given-names></name>. <article-title>Modelling event-related skin conductance responses.</article-title><source>Int J Psychophysiol</source>. <year>2010</year>;<volume>75</volume>:<fpage>349</fpage>–<lpage>56</lpage>. Epub 2010/01/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpsycho.2010.01.005</pub-id> ; PubMed Central PMCID: PMC2877881.<?supplied-pmid 20093150?><pub-id pub-id-type="pmid">20093150</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref079">
                <label>79</label>
                <mixed-citation publication-type="journal"><name><surname>Tustison</surname><given-names>NJ</given-names></name>, <name><surname>Avants</surname><given-names>BB</given-names></name>, <name><surname>Cook</surname><given-names>PA</given-names></name>, <name><surname>Zheng</surname><given-names>YJ</given-names></name>, <name><surname>Egan</surname><given-names>A</given-names></name>, <name><surname>Yushkevich</surname><given-names>PA</given-names></name>, <etal>et al</etal>. <article-title>N4ITK: Improved N3 bias correction</article-title>. <source>IEEE Transactions on Medical Imaging</source>. <year>2010</year>;<volume>29</volume>:<fpage>1310</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1109/TMI.2010.2046908</pub-id> WOS:000278535800009. <?supplied-pmid 20378467?><pub-id pub-id-type="pmid">20378467</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref080">
                <label>80</label>
                <mixed-citation publication-type="journal"><name><surname>Avants</surname><given-names>BB</given-names></name>, <name><surname>Tustison</surname><given-names>NJ</given-names></name>, <name><surname>Song</surname><given-names>G</given-names></name>, <name><surname>Cook</surname><given-names>PA</given-names></name>, <name><surname>Klein</surname><given-names>A</given-names></name>, <name><surname>Gee</surname><given-names>JC</given-names></name>. <article-title>A reproducible evaluation of ANTs similarity metric performance in brain image registration</article-title>. <source>Neuroimage</source>. <year>2011</year>;<volume>54</volume>:<fpage>2033</fpage>–<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.09.025</pub-id> WOS:000286302000027. <?supplied-pmid 20851191?><pub-id pub-id-type="pmid">20851191</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref081">
                <label>81</label>
                <mixed-citation publication-type="journal"><name><surname>Eskildsen</surname><given-names>SF</given-names></name>, <name><surname>Coupé</surname><given-names>P</given-names></name>, <name><surname>Fonov</surname><given-names>V</given-names></name>, <name><surname>Manjón</surname><given-names>JV</given-names></name>, <name><surname>Leung</surname><given-names>KK</given-names></name>, <name><surname>Guizard</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>BEaST: brain extraction based on nonlocal segmentation technique</article-title>. <source>NeuroImage</source>. <year>2012</year>;<volume>59</volume>:<fpage>2362</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.012</pub-id>
<?supplied-pmid 21945694?><pub-id pub-id-type="pmid">21945694</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref082">
                <label>82</label>
                <mixed-citation publication-type="other">BIAC. IXI Dataset London: Imperial College London; 2022 [cited 2022 April 19]. Available from: <ext-link xlink:href="https://brain-development.org/ixi-dataset/" ext-link-type="uri">https://brain-development.org/ixi-dataset/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref083">
                <label>83</label>
                <mixed-citation publication-type="journal"><name><surname>Grabner</surname><given-names>G</given-names></name>, <name><surname>Janke</surname><given-names>AL</given-names></name>, <name><surname>Budge</surname><given-names>MM</given-names></name>, <name><surname>Smith</surname><given-names>D</given-names></name>, <name><surname>Pruessner</surname><given-names>J</given-names></name>, <name><surname>Collins</surname><given-names>DL</given-names></name>. <article-title>Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults.</article-title><source>Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv</source>. <year>2006</year>;<volume>9</volume>:<fpage>58</fpage>–<lpage>66</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref084">
                <label>84</label>
                <mixed-citation publication-type="journal"><name><surname>Lorio</surname><given-names>S</given-names></name>, <name><surname>Fresard</surname><given-names>S</given-names></name>, <name><surname>Adaszewski</surname><given-names>S</given-names></name>, <name><surname>Kherif</surname><given-names>F</given-names></name>, <name><surname>Chowdhury</surname><given-names>R</given-names></name>, <name><surname>Frackowiak</surname><given-names>RS</given-names></name>, <etal>et al</etal>. <article-title>New tissue priors for improved automated classification of subcortical brain structures on MRI</article-title>. <source>Neuroimage</source>. <year>2016</year>;<volume>130</volume>:<fpage>157</fpage>–<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.01.062</pub-id> ; PubMed Central PMCID: PMC4819722.<?supplied-pmid 26854557?><pub-id pub-id-type="pmid">26854557</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref085">
                <label>85</label>
                <mixed-citation publication-type="journal"><name><surname>Jenkinson</surname><given-names>M</given-names></name>, <name><surname>Beckmann</surname><given-names>CF</given-names></name>, <name><surname>Behrens</surname><given-names>TE</given-names></name>, <name><surname>Woolrich</surname><given-names>MW</given-names></name>, <name><surname>Smith</surname><given-names>SM</given-names></name>. <article-title>FSL</article-title>. <source>Neuroimage</source>. <year>2012</year>;<volume>62</volume>:<fpage>782</fpage>–<lpage>90</lpage>. Epub 2011/10/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id> .<?supplied-pmid 21979382?><pub-id pub-id-type="pmid">21979382</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref086">
                <label>86</label>
                <mixed-citation publication-type="journal"><name><surname>McCormick</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Jomier</surname><given-names>J</given-names></name>, <name><surname>Marion</surname><given-names>C</given-names></name>, <name><surname>Ibanez</surname><given-names>L</given-names></name>. <article-title>ITK: enabling reproducible research and open science</article-title>. <source>Frontiers in Neuroinformatics</source>. <year>2014</year>;<volume>8</volume>:<fpage>13</fpage>. Epub 2014/03/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fninf.2014.00013</pub-id> ; PubMed Central PMCID: PMC3929840.<?supplied-pmid 24600387?><pub-id pub-id-type="pmid">24600387</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref087">
                <label>87</label>
                <mixed-citation publication-type="journal"><name><surname>Tillman</surname><given-names>RM</given-names></name>, <name><surname>Stockbridge</surname><given-names>MD</given-names></name>, <name><surname>Nacewicz</surname><given-names>BM</given-names></name>, <name><surname>Torrisi</surname><given-names>S</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Smith</surname><given-names>JF</given-names></name>, <etal>et al</etal>. <article-title>Intrinsic functional connectivity of the central extended amygdala</article-title>. <source>Human Brain Mapping</source>. <year>2018</year>;<volume>39</volume>:<fpage>1291</fpage>–<lpage>312</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/hbm.23917</pub-id>
<?supplied-pmid 29235190?><pub-id pub-id-type="pmid">29235190</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref088">
                <label>88</label>
                <mixed-citation publication-type="other">Wellcome Centre for Human Neuroimaging. SPM London: University College London; 2022 [cited 2022 April 18]. Available from: <ext-link xlink:href="https://fil.ion.ucl.ac.uk/spm/" ext-link-type="uri">https://fil.ion.ucl.ac.uk/spm/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref089">
                <label>89</label>
                <mixed-citation publication-type="journal"><name><surname>Pruim</surname><given-names>RHR</given-names></name>, <name><surname>Mennes</surname><given-names>M</given-names></name>, <name><surname>van Rooij</surname><given-names>D</given-names></name>, <name><surname>Llera</surname><given-names>A</given-names></name>, <name><surname>Buitelaar</surname><given-names>JK</given-names></name>, <name><surname>Beckmann</surname><given-names>CF</given-names></name>. <article-title>ICA-AROMA: a robust ICA-based strategy for removing motion artifacts from fMRI data.</article-title><source>Neuroimage</source>. <year>2015</year>;<volume>112</volume>:<fpage>267</fpage>–<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.02.064</pub-id>
<?supplied-pmid 25770991?><pub-id pub-id-type="pmid">25770991</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref090">
                <label>90</label>
                <mixed-citation publication-type="journal"><name><surname>Theiss</surname><given-names>JD</given-names></name>, <name><surname>Ridgewell</surname><given-names>C</given-names></name>, <name><surname>McHugo</surname><given-names>M</given-names></name>, <name><surname>Heckers</surname><given-names>S</given-names></name>, <name><surname>Blackford</surname><given-names>JU</given-names></name>. <article-title>Manual segmentation of the human bed nucleus of the stria terminalis using 3T MRI.</article-title><source>Neuroimage</source>. <year>2017</year>;<volume>146</volume>:<fpage>288</fpage>–<lpage>92</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.11.047</pub-id> .<?supplied-pmid 27876653?><pub-id pub-id-type="pmid">27876653</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref091">
                <label>91</label>
                <mixed-citation publication-type="journal"><name><surname>Kruger</surname><given-names>O</given-names></name>, <name><surname>Shiozawa</surname><given-names>T</given-names></name>, <name><surname>Kreifelts</surname><given-names>B</given-names></name>, <name><surname>Scheffler</surname><given-names>K</given-names></name>, <name><surname>Ethofer</surname><given-names>T</given-names></name>. <article-title>Three distinct fiber pathways of the bed nucleus of the stria terminalis to the amygdala and prefrontal cortex.</article-title><source>Cortex</source>. <year>2015</year>;<volume>66</volume>:<fpage>60</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cortex.2015.02.007</pub-id><pub-id pub-id-type="pmid">25800506</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref092">
                <label>92</label>
                <mixed-citation publication-type="book"><collab>R Core Team.</collab><source>R: A language and environment for statistical computing.</source><publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>; <year>2022</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref093">
                <label>93</label>
                <mixed-citation publication-type="book"><collab>RStudio Team</collab>. <source>RStudio: Integrated Development for R.</source><publisher-loc>Boston, MA</publisher-loc>: <publisher-name>RStudio PBC</publisher-name>; <year>2022</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref094">
                <label>94</label>
                <mixed-citation publication-type="journal"><name><surname>Revelle</surname><given-names>W.</given-names></name><article-title>psych: Procedures for personality and psychological research</article-title>. <source>The Comprehensive R Archive Network (CRAN)</source>; <year>2022</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref095">
                <label>95</label>
                <mixed-citation publication-type="journal"><name><surname>Kassambara</surname><given-names>A.</given-names></name><article-title>ggpubr: ’ggplot2’ Based Publication Ready Plots: The Comprehensive R Archive Network (CRAN)</article-title>; <year>2022</year> [cited 2022 January 1]. Available from: <ext-link xlink:href="https://cloud.r-project.org/web/packages/ggpubr/index.html" ext-link-type="uri">https://cloud.r-project.org/web/packages/ggpubr/index.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref096">
                <label>96</label>
                <mixed-citation publication-type="journal"><name><surname>Rorden</surname><given-names>C.</given-names></name><article-title>MRIcron: NITRC</article-title>; <year>2019</year> [updated September 2, 2019; cited 2022 April 18]. Available from: <ext-link xlink:href="https://www.nitrc.org/projects/mricron" ext-link-type="uri">https://www.nitrc.org/projects/mricron</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref097">
                <label>97</label>
                <mixed-citation publication-type="journal"><name><surname>Love</surname><given-names>J</given-names></name>, <name><surname>Selker</surname><given-names>R</given-names></name>, <name><surname>Marsman</surname><given-names>M</given-names></name>, <name><surname>Jamil</surname><given-names>T</given-names></name>, <name><surname>Dropmann</surname><given-names>D</given-names></name>, <name><surname>Verhagen</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>JASP: Graphical statistical software for common statistical designs</article-title>. <source>Journal of Statistical Software</source>. <year>2019</year>;<volume>88</volume>:<fpage>1</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.18637/jss.v088.i02</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref098">
                <label>98</label>
                <mixed-citation publication-type="journal"><name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Sarinopoulos</surname><given-names>I</given-names></name>, <name><surname>Maxwell</surname><given-names>JS</given-names></name>, <name><surname>Pizzagalli</surname><given-names>DA</given-names></name>, <name><surname>Lavric</surname><given-names>A</given-names></name>, <name><surname>Davidson</surname><given-names>RJ</given-names></name>. <article-title>Anxiety selectively disrupts visuospatial working memory.</article-title><source>Emotion</source>. <year>2006</year>;<volume>6</volume>:<fpage>40</fpage>–<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/1528-3542.6.1.40</pub-id>
<?supplied-pmid 16637749?><pub-id pub-id-type="pmid">16637749</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref099">
                <label>99</label>
                <mixed-citation publication-type="book"><name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Lapate</surname><given-names>RC</given-names></name>, <name><surname>Davidson</surname><given-names>RJ</given-names></name>, <name><surname>Shackman</surname><given-names>AJ</given-names></name>. <part-title>The nature of emotion: A research agenda for the 21st century</part-title>. In: <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Lapate</surname><given-names>RC</given-names></name>, <name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Davidson</surname><given-names>RJ</given-names></name>, editors. <source>The nature of emotion Fundamental questions</source>. <edition designator="2">2nd ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2018</year>. p. <fpage>403</fpage>–<lpage>17</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref100">
                <label>100</label>
                <mixed-citation publication-type="journal"><name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>. <article-title>Two decades of anxiety neuroimaging research: New insights and a look to the future</article-title><source>American Journal of Psychiatry</source>. <year>2021</year>;<volume>178</volume>:<fpage>106</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1176/appi.ajp.2020.20121733</pub-id>
<?supplied-pmid 33517754?><pub-id pub-id-type="pmid">33517754</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref101">
                <label>101</label>
                <mixed-citation publication-type="journal"><name><surname>Nichols</surname><given-names>T</given-names></name>, <name><surname>Brett</surname><given-names>M</given-names></name>, <name><surname>Andersson</surname><given-names>J</given-names></name>, <name><surname>Wager</surname><given-names>T</given-names></name>, <name><surname>Poline</surname><given-names>JB</given-names></name>. <article-title>Valid conjunction inference with the minimum statistic</article-title>. <source>Neuroimage</source>. <year>2005</year>;<volume>25</volume>:<fpage>653</fpage>–<lpage>60</lpage>. Epub 2005/04/06. S1053-8119(04)00750-5 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.12.005</pub-id> .<?supplied-pmid 15808966?><pub-id pub-id-type="pmid">15808966</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref102">
                <label>102</label>
                <mixed-citation publication-type="journal"><name><surname>Singmann</surname><given-names>H</given-names></name>, <name><surname>Bolker</surname><given-names>B</given-names></name>, <name><surname>Westfall</surname><given-names>J</given-names></name>, <name><surname>Aust</surname><given-names>F</given-names></name>. <article-title>afex: Analysis of factorial experiments.</article-title><source>The Comprehensive R Archive Network (CRAN)</source>; <year>2022</year>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref103">
                <label>103</label>
                <mixed-citation publication-type="journal"><name><surname>Čeko</surname><given-names>M</given-names></name>, <name><surname>Kragel</surname><given-names>PA</given-names></name>, <name><surname>Woo</surname><given-names>C-W</given-names></name>, <name><surname>López-Solà</surname><given-names>M</given-names></name>, <name><surname>Wager</surname><given-names>TD</given-names></name>. <article-title>Common and stimulus-type-specific brain representations of negative affect</article-title>. <source>Nature Neuroscience</source>. <year>2022</year>;<volume>25</volume>:<fpage>760</fpage>–<lpage>70</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41593-022-01082-w</pub-id>
<?supplied-pmid 35637370?><pub-id pub-id-type="pmid">35637370</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref104">
                <label>104</label>
                <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>LJ</given-names></name>, <name><surname>Gianaros</surname><given-names>PJ</given-names></name>, <name><surname>Manuck</surname><given-names>SB</given-names></name>, <name><surname>Krishnan</surname><given-names>A</given-names></name>, <name><surname>Wager</surname><given-names>TD</given-names></name>. <article-title>A sensitive and specific neural signature for picture-induced negative affect</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>:<fpage>e1002180</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pbio.1002180</pub-id> ; PubMed Central PMCID: PMC4476709.<?supplied-pmid 26098873?><pub-id pub-id-type="pmid">26098873</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref105">
                <label>105</label>
                <mixed-citation publication-type="journal"><name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Oler</surname><given-names>JA</given-names></name>, <name><surname>Shelton</surname><given-names>SE</given-names></name>, <name><surname>Davidson</surname><given-names>RJ</given-names></name>, <name><surname>Kalin</surname><given-names>NH</given-names></name>. <article-title>Neural mechanisms underlying heterogeneity in the presentation of anxious temperament</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2013</year>;<volume>110</volume>:<fpage>6145</fpage>–<lpage>50</lpage>. 1214364110 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1214364110</pub-id> .<?supplied-pmid 23538303?><pub-id pub-id-type="pmid">23538303</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref106">
                <label>106</label>
                <mixed-citation publication-type="journal"><name><surname>Taschereau-Dumouchel</surname><given-names>V</given-names></name>, <name><surname>Michel</surname><given-names>M</given-names></name>, <name><surname>Lau</surname><given-names>H</given-names></name>, <name><surname>Hofmann</surname><given-names>SG</given-names></name>, <name><surname>LeDoux</surname><given-names>JE</given-names></name>. <article-title>Putting the "mental" back in "mental disorders": a perspective from research on fear and anxiety.</article-title><source>Mol Psychiatry</source>. <year>2022</year>;<volume>27</volume>:<fpage>1322</fpage>–<lpage>30</lpage>. Epub 2022/01/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41380-021-01395-5</pub-id> ; PubMed Central PMCID: PMC9095479.<?supplied-pmid 35079126?><pub-id pub-id-type="pmid">35079126</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref107">
                <label>107</label>
                <mixed-citation publication-type="journal"><name><surname>Patnode</surname><given-names>CD</given-names></name>, <name><surname>Henderson</surname><given-names>JT</given-names></name>, <name><surname>Coppola</surname><given-names>EL</given-names></name>, <name><surname>Melnikow</surname><given-names>J</given-names></name>, <name><surname>Durbin</surname><given-names>S</given-names></name>, <name><surname>Thomas</surname><given-names>RG</given-names></name>. <article-title>Interventions for tobacco cessation in adults, including pregnant persons: Updated evidence report and systematic review for the US Preventive Services Task Force</article-title>. <source>JAMA</source>. <year>2021</year>;<volume>325</volume>:<fpage>280</fpage>–<lpage>98</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.2020.23541</pub-id>
<?supplied-pmid 33464342?><pub-id pub-id-type="pmid">33464342</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref108">
                <label>108</label>
                <mixed-citation publication-type="journal"><name><surname>Baker</surname><given-names>TB</given-names></name>, <name><surname>McCarthy</surname><given-names>DE</given-names></name>. <article-title>Smoking treatment: A report card on progress and challenges</article-title>. <source>Annu Rev Clin Psychol</source>. <year>2021</year>;<volume>17</volume>:<fpage>1</fpage>–<lpage>30</lpage>. Epub 2021/05/09. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-081219-090343</pub-id> .<?supplied-pmid 33962535?><pub-id pub-id-type="pmid">33962535</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref109">
                <label>109</label>
                <mixed-citation publication-type="journal"><name><surname>Schultz</surname><given-names>ME</given-names></name>, <name><surname>Fronk</surname><given-names>GE</given-names></name>, <name><surname>Jaume</surname><given-names>N</given-names></name>, <name><surname>Magruder</surname><given-names>KP</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Stressor-elicited smoking and craving during a smoking cessation attempt</article-title>. <source>Journal of Psychopathology and Clinical Science</source>. <year>2022</year>;<volume>131</volume>:<fpage>73</fpage>–<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/abn0000702</pub-id>
<?supplied-pmid 34881919?><pub-id pub-id-type="pmid">34881919</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref110">
                <label>110</label>
                <mixed-citation publication-type="journal"><name><surname>Cinciripini</surname><given-names>PM</given-names></name>, <name><surname>Robinson</surname><given-names>JD</given-names></name>, <name><surname>Karam-Hage</surname><given-names>M</given-names></name>, <name><surname>Minnix</surname><given-names>JA</given-names></name>, <name><surname>Lam</surname><given-names>C</given-names></name>, <name><surname>Versace</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal</article-title>. <source>JAMA Psychiatry</source>. <year>2013</year>;<volume>70</volume>:<fpage>522</fpage>–<lpage>33</lpage>. Epub 2013/03/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.678</pub-id> ; PubMed Central PMCID: PMC4128024.<?supplied-pmid 23536105?><pub-id pub-id-type="pmid">23536105</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref111">
                <label>111</label>
                <mixed-citation publication-type="journal"><name><surname>West</surname><given-names>R</given-names></name>, <name><surname>Baker</surname><given-names>CL</given-names></name>, <name><surname>Cappelleri</surname><given-names>JC</given-names></name>, <name><surname>Bushmakin</surname><given-names>AG</given-names></name>. <article-title>Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt</article-title>. <source>Psychopharmacology (Berl).</source><year>2008</year>;<volume>197</volume>:<fpage>371</fpage>–<lpage>7</lpage>. Epub 2007/12/18. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00213-007-1041-3</pub-id> .<?supplied-pmid 18084743?><pub-id pub-id-type="pmid">18084743</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref112">
                <label>112</label>
                <mixed-citation publication-type="journal"><name><surname>Logothetis</surname><given-names>NK</given-names></name>. <article-title>What we can do and what we cannot do with fMRI</article-title>. <source>Nature</source>. <year>2008</year>;<volume>453</volume>:<fpage>869</fpage>–<lpage>78</lpage>. nature06976 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature06976</pub-id> .<?supplied-pmid 18548064?><pub-id pub-id-type="pmid">18548064</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref113">
                <label>113</label>
                <mixed-citation publication-type="journal"><name><surname>Zhao-Shea</surname><given-names>R</given-names></name>, <name><surname>DeGroot</surname><given-names>SR</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Vallaster</surname><given-names>M</given-names></name>, <name><surname>Pang</surname><given-names>X</given-names></name>, <name><surname>Su</surname><given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal.</article-title><source>Nat Commun.</source><year>2015</year>;<volume>6</volume>:<fpage>6770</fpage>. Epub 2015/04/22. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ncomms7770</pub-id> ; PubMed Central PMCID: PMC4405813.<?supplied-pmid 25898242?><pub-id pub-id-type="pmid">25898242</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref114">
                <label>114</label>
                <mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>D</given-names></name>, <name><surname>Vishwakarma</surname><given-names>PK</given-names></name>, <name><surname>Patel</surname><given-names>R</given-names></name>, <name><surname>Jain</surname><given-names>NS</given-names></name>. <article-title>Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice</article-title>. <source>Behavioural Brain Research</source>. <year>2021</year>;<volume>399</volume>:<fpage>112997</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bbr.2020.112997</pub-id><?supplied-pmid 33166570?><pub-id pub-id-type="pmid">33166570</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref115">
                <label>115</label>
                <mixed-citation publication-type="journal"><name><surname>Qi</surname><given-names>X</given-names></name>, <name><surname>Guzhva</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Febo</surname><given-names>M</given-names></name>, <name><surname>Shan</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>KKW</given-names></name>, <etal>et al</etal>. <article-title>Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats</article-title>. <source>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology</source>. <year>2016</year>;<volume>26</volume>:<fpage>1378</fpage>–<lpage>89</lpage>. Epub 2016/07/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.euroneuro.2016.07.007</pub-id> ; PubMed Central PMCID: PMC5067082.<?supplied-pmid 27461514?><pub-id pub-id-type="pmid">27461514</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref116">
                <label>116</label>
                <mixed-citation publication-type="journal"><name><surname>Hogle</surname><given-names>JM</given-names></name>, <name><surname>Curtin</surname><given-names>JJ</given-names></name>. <article-title>Sex differences in negative affective response during nicotine withdrawal.</article-title><source>Psychophysiology</source>. <year>2006</year>;<volume>43</volume>:<fpage>344</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1469-8986.2006.00406.x</pub-id> .<?supplied-pmid 16916430?><pub-id pub-id-type="pmid">16916430</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref117">
                <label>117</label>
                <mixed-citation publication-type="journal"><name><surname>Joëls</surname><given-names>M</given-names></name>, <name><surname>Baram</surname><given-names>TZ</given-names></name>. <article-title>The neuro-symphony of stress.</article-title><source>Nat Rev Neurosci</source>. <year>2009</year>;<volume>10</volume>:<fpage>459</fpage>–<lpage>66</lpage>. Epub 2009/04/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrn2632</pub-id> ; PubMed Central PMCID: PMC2844123.<?supplied-pmid 19339973?><pub-id pub-id-type="pmid">19339973</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref118">
                <label>118</label>
                <mixed-citation publication-type="journal"><name><surname>Griebel</surname><given-names>G</given-names></name>, <name><surname>Holmes</surname><given-names>A</given-names></name>. <article-title>50 years of hurdles and hope in anxiolytic drug discovery.</article-title><source>Nat Rev Drug Discov</source>. <year>2013</year>;<volume>12</volume>:<fpage>667</fpage>–<lpage>87</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrd4075</pub-id> ; PubMed Central PMCID: PMC4176700.<?supplied-pmid 23989795?><pub-id pub-id-type="pmid">23989795</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref119">
                <label>119</label>
                <mixed-citation publication-type="journal"><name><surname>Dunlop</surname><given-names>BW</given-names></name>, <name><surname>Binder</surname><given-names>EB</given-names></name>, <name><surname>Iosifescu</surname><given-names>D</given-names></name>, <name><surname>Mathew</surname><given-names>SJ</given-names></name>, <name><surname>Neylan</surname><given-names>TC</given-names></name>, <name><surname>Pape</surname><given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder</article-title>. <source>Biol Psychiatry</source>. <year>2017</year>;<volume>82</volume>:<fpage>866</fpage>–<lpage>74</lpage>. Epub 2017/08/11. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biopsych.2017.06.024</pub-id> ; PubMed Central PMCID: PMC5683912.<?supplied-pmid 28793974?><pub-id pub-id-type="pmid">28793974</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref120">
                <label>120</label>
                <mixed-citation publication-type="journal"><name><surname>Grillon</surname><given-names>C</given-names></name>, <name><surname>Hale</surname><given-names>E</given-names></name>, <name><surname>Lieberman</surname><given-names>L</given-names></name>, <name><surname>Davis</surname><given-names>A</given-names></name>, <name><surname>Pine</surname><given-names>DS</given-names></name>, <name><surname>Ernst</surname><given-names>M</given-names></name>. <article-title>The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle</article-title>. <source>Neuropsychopharmacology</source>. <year>2015</year>;<volume>40</volume>:<fpage>1064</fpage>–<lpage>71</lpage>. Epub 2014/11/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2014.316</pub-id> ; PubMed Central PMCID: PMC4367474.<?supplied-pmid 25430779?><pub-id pub-id-type="pmid">25430779</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref121">
                <label>121</label>
                <mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>ME</given-names></name>, <name><surname>Andrews</surname><given-names>RD</given-names></name>, <name><surname>van der Ark</surname><given-names>P</given-names></name>, <name><surname>Brown</surname><given-names>T</given-names></name>, <name><surname>Mannaert</surname><given-names>E</given-names></name>, <name><surname>Steckler</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects</article-title>. <source>Psychopharmacology (Berl).</source><year>2010</year>;<volume>208</volume>:<fpage>109</fpage>–<lpage>19</lpage>. Epub 2009/11/17. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00213-009-1714-1</pub-id> .<?supplied-pmid 19911168?><pub-id pub-id-type="pmid">19911168</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref122">
                <label>122</label>
                <mixed-citation publication-type="journal"><name><surname>Portugal</surname><given-names>GS</given-names></name>, <name><surname>Wilkinson</surname><given-names>DS</given-names></name>, <name><surname>Kenney</surname><given-names>JW</given-names></name>, <name><surname>Sullivan</surname><given-names>C</given-names></name>, <name><surname>Gould</surname><given-names>TJ</given-names></name>. <article-title>Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning</article-title>. <source>Behavior Genetics</source>. <year>2012</year>;<volume>42</volume>:<fpage>133</fpage>–<lpage>50</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10519-011-9489-7</pub-id>
<?supplied-pmid 21822688?><pub-id pub-id-type="pmid">21822688</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref123">
                <label>123</label>
                <mixed-citation publication-type="journal"><name><surname>Stewart</surname><given-names>AM</given-names></name>, <name><surname>Nguyen</surname><given-names>M</given-names></name>, <name><surname>Poudel</surname><given-names>MK</given-names></name>, <name><surname>Warnick</surname><given-names>JE</given-names></name>, <name><surname>Echevarria</surname><given-names>DJ</given-names></name>, <name><surname>Beaton</surname><given-names>EA</given-names></name>, <etal>et al</etal>. <article-title>The failure of anxiolytic therapies in early clinical trials: what needs to be done.</article-title><source>Expert Opin Investig Drugs</source>. <year>2015</year>;<volume>24</volume>:<fpage>543</fpage>–<lpage>56</lpage>. Epub 2015/03/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1517/13543784.2015.1019063</pub-id> .<?supplied-pmid 25727478?><pub-id pub-id-type="pmid">25727478</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref124">
                <label>124</label>
                <mixed-citation publication-type="journal"><name><surname>Kenwood</surname><given-names>MM</given-names></name>, <name><surname>Kalin</surname><given-names>NH</given-names></name>. <article-title>Nonhuman primate models to explore mechanisms underlying early-life temperamental anxiety</article-title>. <source>Biological Psychiatry</source>. <year>2021</year>;<volume>89</volume>:<fpage>659</fpage>–<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.biopsych.2020.08.028</pub-id>
<?supplied-pmid 33229035?><pub-id pub-id-type="pmid">33229035</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref125">
                <label>125</label>
                <mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>AS</given-names></name>, <name><surname>Kalin</surname><given-names>NH</given-names></name>. <article-title>A translational neuroscience approach to understanding the development of social anxiety disorder and its pathophysiology</article-title>. <source>American Journal of Psychiatry</source>. <year>2014</year>;<volume>171</volume>:<fpage>1162</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1176/appi.ajp.2014.14040449</pub-id>
<?supplied-pmid 25157566?><pub-id pub-id-type="pmid">25157566</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref126">
                <label>126</label>
                <mixed-citation publication-type="book"><name><surname>Magnusson</surname><given-names>K.</given-names></name><part-title>Interpreting Cohen’s d effect size</part-title>. <source>An interactive visualization Stockholm,</source><publisher-loc>Sweden</publisher-loc>: <publisher-name>Centre for Psychiatry Research, Karolinska Institutet</publisher-name>; <year>2022</year> [cited 2022 August 1]. Available from: <ext-link xlink:href="https://rpsychologist.com/cohend/" ext-link-type="uri">https://rpsychologist.com/cohend/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref127">
                <label>127</label>
                <mixed-citation publication-type="other">FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) 2020 [updated December 28; cited 2021 January 2]. Available from: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK326791/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK326791/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref128">
                <label>128</label>
                <mixed-citation publication-type="journal"><name><surname>Shackman</surname><given-names>AJ</given-names></name>, <name><surname>Fox</surname><given-names>AS</given-names></name>. <article-title>Getting serious about variation: Lessons for clinical neuroscience</article-title>. <source>Trends in Cognitive Sciences</source>. <year>2018</year>;<volume>22</volume>:<fpage>368</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">29576465</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref129">
                <label>129</label>
                <mixed-citation publication-type="journal"><name><surname>Chavanne</surname><given-names>AV</given-names></name>, <name><surname>Robinson</surname><given-names>OJ</given-names></name>. <article-title>The overlapping neurobiology of adaptive and pathological anxiety: a meta-analysis of functional neural activation</article-title>. <source>American Journal of Psychiatry</source>. <year>2021</year>;<volume>178</volume>:<fpage>156</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2020.19111153</pub-id>.<pub-id pub-id-type="pmid">33054384</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref130">
                <label>130</label>
                <mixed-citation publication-type="journal"><name><surname>Fullana</surname><given-names>MA</given-names></name>, <name><surname>Harrison</surname><given-names>BJ</given-names></name>, <name><surname>Soriano-Mas</surname><given-names>C</given-names></name>, <name><surname>Vervliet</surname><given-names>B</given-names></name>, <name><surname>Cardoner</surname><given-names>N</given-names></name>, <name><surname>Àvila-Parcet</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Neural signatures of human fear conditioning: An updated and extended meta-analysis of fMRI studies</article-title>. <source>Molecular Psychiatry</source>. <year>2016</year>;<volume>21</volume>:<fpage>500</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/mp.2015.882016-17782-008</pub-id>
<?supplied-pmid 26122585?><pub-id pub-id-type="pmid">26122585</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref131">
                <label>131</label>
                <mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>M.</given-names></name><article-title>Neural systems involved in fear and anxiety measured with fear-potentiated startle.</article-title><source>Am Psychol</source>. <year>2006</year>;<volume>61</volume>:<fpage>741</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037/0003-066X.61.8.741</pub-id> .<?supplied-pmid 17115806?><pub-id pub-id-type="pmid">17115806</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref132">
                <label>132</label>
                <mixed-citation publication-type="journal"><name><surname>Avery</surname><given-names>SN</given-names></name>, <name><surname>Clauss</surname><given-names>JA</given-names></name>, <name><surname>Blackford</surname><given-names>JU</given-names></name>. <article-title>The human BNST: Functional role in anxiety and addiction</article-title>. <source>Neuropsychopharmacology</source>. <year>2016</year>;<volume>41</volume>:<fpage>126</fpage>–<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/npp.2015.185</pub-id> .<?supplied-pmid 26105138?><pub-id pub-id-type="pmid">26105138</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref133">
                <label>133</label>
                <mixed-citation publication-type="journal"><name><surname>Klumpers</surname><given-names>F</given-names></name>, <name><surname>Kroes</surname><given-names>MCW</given-names></name>, <name><surname>Baas</surname><given-names>J</given-names></name>, <name><surname>Fernandez</surname><given-names>G</given-names></name>. <article-title>How human amygdala and bed nucleus of the stria terminalis may drive distinct defensive responses</article-title>. <source>J Neurosci</source>. <year>2017</year>;<volume>37</volume>:<fpage>9645</fpage>–<lpage>56</lpage>. Epub 2017/09/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3830-16.2017</pub-id> .<?supplied-pmid 28893930?><pub-id pub-id-type="pmid">28893930</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref134">
                <label>134</label>
                <mixed-citation publication-type="journal"><name><surname>Somerville</surname><given-names>LH</given-names></name>, <name><surname>Wagner</surname><given-names>DD</given-names></name>, <name><surname>Wig</surname><given-names>GS</given-names></name>, <name><surname>Moran</surname><given-names>JM</given-names></name>, <name><surname>Whalen</surname><given-names>PJ</given-names></name>, <name><surname>Kelley</surname><given-names>WM</given-names></name>. <article-title>Interactions between transient and sustained neural signals support the generation and regulation of anxious emotion</article-title>. <source>Cereb Cortex</source>. <year>2013</year>;<volume>23</volume>:<fpage>49</fpage>–<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/bhr373</pub-id> ; PubMed Central PMCID: PMC3513951.<?supplied-pmid 22250290?><pub-id pub-id-type="pmid">22250290</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref135">
                <label>135</label>
                <mixed-citation publication-type="other">NIMH. Construct: Potential Threat ("Anxiety") 2020 [cited 2020 May 31]. Available from: <ext-link xlink:href="https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/constructs/potential-threat-anxiety.shtml" ext-link-type="uri">https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/constructs/potential-threat-anxiety.shtml</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref136">
                <label>136</label>
                <mixed-citation publication-type="other">NIMH. Construct: Acute Threat ("Fear") 2020 [cited 2020 May 31]. Available from: <ext-link xlink:href="https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/constructs/acute-threat-fear.shtml" ext-link-type="uri">https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/constructs/acute-threat-fear.shtml</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0288544.ref137">
                <label>137</label>
                <mixed-citation publication-type="journal"><name><surname>Murty</surname><given-names>D</given-names></name>, <name><surname>Song</surname><given-names>S</given-names></name>, <name><surname>Morrow</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Hu</surname><given-names>K</given-names></name>, <name><surname>Pessoa</surname><given-names>L</given-names></name>. <article-title>Distributed and multifaceted effects of threat and safety</article-title>. <source>J Cogn Neurosci</source>. <year>2022</year>;<volume>34</volume>:<fpage>495</fpage>–<lpage>516</lpage>. Epub 2021/12/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1162/jocn_a_01807</pub-id> ; PubMed Central PMCID: PMC8832158.<?supplied-pmid 34942650?><pub-id pub-id-type="pmid">34942650</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0288544.ref138">
                <label>138</label>
                <mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>J.</given-names></name><article-title>A power primer.</article-title><source>Psychological Bulletin</source>. <year>1992</year>;<volume>112</volume>:<fpage>155</fpage>–<lpage>59</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1037//0033-2909.112.1.155</pub-id>
<?supplied-pmid 19565683?><pub-id pub-id-type="pmid">19565683</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
